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One in four of the top 200 selling pharmaceutical drugs contain a chiral amine. Chiral 
amines often require difficult synthesis through traditional heterogeneous catalysts. As a 
result, the use of biocatalysts in industrial applications to create amines has been 
increasingly desired and developed. Amine dehydrogenases (AmDHs) are a novel class 
of enzymes that catalyze the reaction of prochiral ketones to chiral amines. Through 
protein engineering on existing amino acid dehydrogenase scaffolds, ketones instead of 
carboxylic acids are now substrates of the AmDH. This work will describe the use of 
biocatalysts, specifically the AmDHs, as a green alternative to catalyze ketones to 
enantiomerically pure amines. 
 Three different amine dehydrogenases have been developed so far: leucine amine 
dehydrogenase (L-AmDH), phenylalanine amine dehydrogenase (F-AmDH) and 
chimeric amine dehydrogenase (cFL1-AmDH). The AmDHs exhibits excellent (R)-
enantioselectivity (>99% e.e.) and can also catalyze the reverse oxidative deamination 
reaction of amine to ketone. This work will focus on the further development and 
application of the amine dehydrogenases. Many of the desired pharmaceutical 
intermediate targets are bulkier substrates and exhibit low solubility. The first goal of this 
work will focus on the development of a biphasic organic solvent reaction system in 
order to allow for conversion of hydrophobic substrates. In a biphasic system, the enzyme 
and hydrophilic cofactors are envisioned to stay in the aqueous phase, while the 
hydrophobic substrate will partition from the organic top phase, thereby, reducing any 
chance of enzyme deactivation from the solvent. 
 
 xxi
The second goal of this work will involve protein and reaction engineering to 
obtain mechanistic insight on the binding of the ammonia substrate of the amine 
dehydrogenase. Amino acid mutations were performed within the active site expecting to 
improve the electrostatic interactions and binding toward the ammonia substrate. The 
activity of the AmDH was tested in various buffer conditions and substrate 
concentrations in order to determine its mechanism. The third goal of this work will focus 
on kinetic resolution of racemic chiral amine mixtures to allow for isolation of the 
opposite enantiomer. An AmDH naturally catalyzes formation of only the (R)-
enantiomer, but many pharmaceutical drug intermediates are comprised of the (S)-
enantiomer. Through optimization of reaction conditions, the enantiomerically pure (S)-
amine was successfully obtained through complete oxidative deamination of the racemic 
amine mixture. The substrate profile of the AmDH was additionally investigated and 
mutations were introduced to improve the activity in the oxidative deamination direction.  
The potential of AmDHs as a biocatalytic alternative for production toward chiral 
amines has led us to develop a scalable, efficient purification strategy for these enzymes. 
An aqueous two-phase extraction (ATPE) system consists of a polymer top phase and an 
aqueous salt buffer for the bottom phase. The ATPE can selectively partition the desired 
enzyme into the top layer, while the remaining cell debris and lysate remain in the bottom 
layer, resulting in a simple and efficient enzymatic purification. This was successfully 
achieved for the phenylalanine amine dehydrogenase, F-AmDH, and further work has 
applied the ATPE to other dehydrogenases. Furthermore, the phase diagram of the ATPE 
consisting of a binodal curve and tie-lines was established.  
 
 xxii
Lastly, the future application and conclusion of this work will be discussed with a 
focus on expanding the substrate specificity, improving the binding toward the ammonia 







Biocatalysis is the use of natural catalysts, such as enzymes, to perform chemical 
transformations. Enzymes are widely known for their rate enhancement that can range 
from 107 to 1019-fold increase in reaction rates [1]. Enzymes also feature high selectivity, 
including regio-, chemo-, and enantioselectivity. They operate under environmentally 
friendly process conditions involving moderate temperature, pressure and aqueous 
reaction mediums [2, 3]. In addition, enzymes are both renewable and biodegradable. The 
use of biocatalysts as a green alternative to traditional heterogeneous catalysts has been 
increasingly investigated in the synthesis of chemical compounds and active 
pharmaceutical ingredients (APIs) [4, 5].  
 
1.2 Chiral Amines 
Chiral amine compounds with high enantioselectivity can be difficult to prepare by many 
types of traditional catalysts. In 2006, 80% of small-molecule pharmaceutical drugs 
approved by the FDA contained chiral centers and 75% were single enantiomers [6]. 
Enantiomers have the same physical properties but can exhibit different chemical 
properties in a chiral environment, such as the human body and with protein receptors; 
therefore, they should be treated as separate compounds during drug development. Some 
enantiomers have shown to be inactive or toxic in the human body. For the case of the 
anti-inflammatory drug ibuprofen, the (S)-enantiomer is a hundred times more potent 
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than the (R)-enantiomer [7]. Each enantiomer requires a separate toxicity study and 
clinical trial so it is important to produce enantiomerically pure pharmaceutical drugs.  
 Chiral products, including chiral amines, can be synthesized through three 
catalytic routes: 1) resolution of a racemic mixture, 2) chiral synthon pool and 3) 
asymmetric synthesis [8]. In kinetic resolution, the catalyst has different reaction rates 
toward each enantiomer and the undesired enantiomer can be reacted away. This 
procedure leaves a mixture containing 50% of the product from the undesired enantiomer 
and 50% of the desired pure enantiomer. The second method involves a chiral starting 
material that is incorporated into a chiral product. The third method focuses on 
asymmetric synthesis from a prochiral starting material to develop a final chiral molecule 
product.  
 In 2010, 80% of the 200 most prescribed brand name drugs in the U.S. contain 
nitrogen, with a chiral amine in 40% of these compounds [9]. Examples of current APIs 
with amine groups containing chiral centers include Januvia® and Tamiflu® (Figure 1.1).  
Heterogeneous catalysts to enantiomerically pure amines often feature low selectivity, 
less environmentally friendly solvents and difficult separation of the amine product [10-
13]. As previously mentioned, biocatalysts are desired to create enantiomerically pure 
amines because of their selectivity and mild processing conditions. The development of 
biocatalysts suitable towards the production of chiral amines is still relatively limited and 
unestablished. The American Chemical Society’s Green Chemistry Institute 
Pharmaceutical Roundtable (ACS GCIPR) has focused on increasing green chemistry 
such as the use of biocatalysts into the pharmaceutical industry. In 2007, the 
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Pharmaceutical Roundtable determined amination of ketones as a top aspirational 
reaction (Table 1.1) [14].  
 
Figure 1.1 Examples of pharmaceutical drugs with chiral amines 
 
 
Table 1.1 Aspirational reactions challenging the pharmaceutical industry determined by 
the ACS GCI Pharmaceutical Roundtable [14] 
Research Area Number of Roundtable 
companies voting for 
research area as a priority  
C-H activation of aromatics (cross coupling reactions 
avoiding the preparation of haloaromatics) 
6 votes 
Aldehyde or ketone + NH3 + “X” to give chiral amine 4 votes Asymmetric hydrogenation of unfunctionalized 
olefins/enamines/imines 
4 votes 
New greener fluorination methods 4 votes 
N-Centered chemistry avoiding azides, hydrazine etc 3 votes 
Asymmetric hydramination 2 votes 
Green sources of electrophilic nitrogen (not TsN3, nitroso, or diimide) 
2 votes 






1.3 Transaminases (TAs) 
 
The most established and well-known enzymatic route to chiral amines involves 
transaminases. ω-transaminase transfers an amine group from an amino donor onto the 
carbonyl moiety of the amino acceptor (Figure 1.2). The main disadvantages of 
transaminases include the use of a sacrificial amine source and the need to overcome an 
unfavorable equilibrium. The ketone co-product must be constantly removed during the 
reaction to shift the equilibrium and prevent product inhibition in order to achieve 
conversion much beyond about 50% [15-18].  
 
Figure 1.2 Transaminase reaction scheme  
 
Transaminases transfer an amino group from an amine donor to a carbonyl acceptor with 
PLP as a cofactor. Transaminases possess a dual binding pocket, with a large binding 
pocket accommodating bulkier substituents and a smaller pocket for smaller substituents. 
[19, 20]. This smaller pocket causes the ω-transaminase to naturally possess steric 
constraints that limit the enzyme to convert substituents smaller than a propyl group. 
Recent work has been successfully developed to expand its limited substrate range to 
pharmaceutical intermediates [21-24]. Transaminases naturally possess (S)-selectivity but 
recently (R)-selective enzymes have been developed [25, 26]. In addition, recent work 
 
 5
has focused on increased stability [27] and by-product removal activity assays to allow 
for favorable equilibrium and higher conversion [28, 29].  
 The most successful application of biocatalysts for chiral amine production was 
achieved by Merck and Codexis involving an (R)-selective transaminase for sitagliptin 
(Januvia®) (Figure 1.3) [30].  
 Figure 1.3 Enzymatic transamination for the synthesis of Sitagliptin [30] 
 
 
1.4 Amine Dehydrogenases (AmDHs) 
Amine dehydrogenases were recently developed through protein engineering using 
existing amino acid dehydrogenase as scaffolds (Figure 1.4). The amine dehydrogenase 
converts the analogous ketone (as opposed to the alpha-keto acid, the substrate of the 
amino acid dehydrogenase) to its respective amine with the addition of cofactor NADH 
and ammonia (Figure 1.5) [31]. Reductive amination of a ketone by amine 
dehydrogenases offer a distinct advantage over transamination by avoiding equilibrium 
limitations and requiring a sacrificial amine donor- it is the most direct biocatalytic route 
to produce chiral amines. Prior to this work, there was no developed enzymatic route 
toward amines by amination of prochiral ketones. Three different amine dehydrogenases 
have been developed: leucine amine dehydrogenase (L-AmDH) [32], phenylalanine 
amine dehydrogenase (F-AmDH) [33] and a chimeric amine dehydrogenase (cFL1-
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AmDH) [34] (Figure 1.5). Each amine dehydrogenase has a different ketone substrate 
profile. 
 
 Figure 1.4  Reaction scheme of wild-type amino acid dehydrogenase (A) and amine 
dehydrogenase (B) [31] 
 
 
 Figure 1.5 Reaction scheme for a model substrate of leucine amine dehydrogenase (L-
AmDH) (A), phenylalanine amine dehydrogenase (F-AmDH) (B), and chimeric amine 







1.4.1 Leucine Amine Dehydrogenase (L-AmDH) 
The first amine dehydrogenase developed was the leucine amine dehydrogenase (L-
AmDH). L-AmDH was developed from mutations to the active site of the Bacillus 
stearothermophilus leucine dehydrogenase. L-AmDH converts methyl isobutyl ketone 
(MIBK) to (R)-1,3-dimethylbutylamine (1,3-DMBA). A high-throughput absorbance-
based assay based on NADH/NAD+ at 340 nm and cell density measurement at 600 nm 
was employed to screen variants of the two-site library 67DDK/260DDK.  Eleven rounds 
of protein engineering resulted in a successful variant K67S/N260L with a kcat value of 
0.46 s-1. Lab-scale reaction on a 30 mg scale with L-AmDH and cofactor regeneration 
with formate dehydrogenase (FDH) resulted in 92.5% conversion and 99.8% e.e. [32]. 
 
1.4.2 Phenylalanine Amine Dehydrogenase (F-AmDH) 
The second amine dehydrogenase developed was the phenylalanine amine dehydrogenase 
(F-AmDH) and was created by introducing mutations to Bacillus badius phenylalanine 
dehydrogenase scaffold. F-AmDH converts 4-fluoro phenylacetone (pFPA) to (R)-1-(4-
fluorophenyl)-propyl-2-amine (pFPAm). Phenylacetone was not used because it is 
regulated as a Schedule 2 controlled substance. Another high-throughput library was 
screened for F-AmDH activity but, unexpectedly, the best F-AmDH variant consisted of 
the same two mutations present in the L-AmDH. Use of a restricted codon DDK at each 
of the two mutation sites was implemented for more efficient screening. Twenty-one 
unique F-AmDH variants were identified with kcat values greater than 1 s-1. The top 
variant (K77S/N275L) achieved a kcat of 6.85 s-1 in the presence of all saturated 
substrates. Successful lab-scale reaction with a cofactor regeneration system was 
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achieved with 93% conversion and 99.8% e.e. (Figure 1.6) [33]. In addition, the F-
AmDH from Rhodococcus sp. M4 has been recently developed [35].   
 
 Figure 1.6 F-AmDH reaction scheme with cofactor regeneration [33] 
 
1.4.3 Chimeric Amine Dehydrogenase (cFL1-AmDH) 
The chimeric amine dehydrogenase (cFL1-AmDH) was created by combining the ketone-
binding domain from the F-AmDH (residues 1-151 of B. badius PheDH) and the cofactor 
binding domain from the L-AmDH (residues 141-368 of B. stearothermophilus LeuDH).  
The cFL1-AmDH possesses unique properties as it can now take benzylic ketones as 
substrates, in addition to the substrates of F-AmDH. The model reaction for cFL1-AmDH 
is the conversion of acetophenone to (R)-1-phenylethylamine (1-PEA). In addition, cFL1-
AmDH has a higher temperature optimum of 60°C compared to the F-AmDH 
temperature optimum of 50°C. Thus, the development of cFL1-AmDH has further 





1.4.4 Chiral cascades with alcohol dehydrogenases (ADH)/ amine dehydrogenases 
(AmDHs)  
Multi-enzyme cascade reactions to synthesize chiral amines are highly desired because 
they avoid isolation and purification of intermediates, use less raw materials and can be 
used to overcome thermodynamically unfavorable equilibriums [36, 37]. The alcohol 
dehydrogenase (ADH) oxidizes the alcohol to form the ketone and the amine 
dehydrogenase (AmDH) subsequently reductively aminates the ketone to a chiral amine 
(Figure 1.7). This reaction is redox-neutral and allows the cofactor NADH/NAD+ to be 
constantly recycled between both reactions. Through this cascade reaction, high 
conversion was achieved (up to 96%) and excellent enantioselectivity (>99% e.e.) was 
obtained for the (R)-amine [38-40].  
 
 Figure 1.7 ADH/AmDH reaction scheme to create chiral amines from alcohols [39] 
 
1.5 Cofactor Regeneration 
Dehydrogenases, including the amine dehydrogenase, use nicotinamide cofactors 
NADH/NAD+ as substrates. However, due to their high costs, it is not economic to use 
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the cofactor in stoichiometric quantities (Table 1.2). Therefore, this section will focus on 
implementation of an in situ cofactor regeneration system paired with the amine 
dehydrogenase. 
 
Table 1.2 Cost of nicotinamide cofactors [41] and regeneration systems [42] 
Compound Price ($/mol) 
NADH 3,580 
NADPH 96,530 
HCOONH3 (formate) 0.2 Glucose 0.2 
 
1.5.1 Formate Dehydrogenase 
Reduction of the oxidized form of the NADH cofactor can be performed with several 
enzymes (Figure 1.8). In this thesis work, the cofactor regeneration enzyme glucose 
dehydrogenase (GDH) [43] was replaced with Candida boidinii formate dehydrogenase 
(Cb-FDH) [44-47]. The main advantage is the reaction can be performed in an 
ammonium formate solution, which i) buffers at a pH value of around 6.8, ii) supplies 
NH4+ and formate as the substrate for AmDH and Cb-FDH, respectively, thus, leading to 
improved atom economy. Another advantage of employing Cb-FDH is the co-product 
carbon dioxide, which is more easily removed than gluconic acid, the co-product of the 
GDH regeneration system. As gluconic acid is formed in the glucose dehydrogenase 
reaction, the pH value will eventually drop and the reaction system will no longer be at 
its optimum. A base will have to constantly be added to keep the optimum pH value. In 
addition, the Cb-FDH had a favorably wide range for pH optimum from 6.0-9.0, which is 
important because the amine dehydrogenase has a basic pH optimum of 9.6.The C23S 
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mutation was added to the FDH to improve it thermostability but there was no 
improvement observed in its thermostability or kinetic constants.  
 
 Figure 1.8 NADH regeneration scheme with various enzymes 
 
 
1.5.2 NADH Oxidase 
NADH oxidases (Noxs) catalyze the reaction from NADH to NAD+ and will be utilized 
in kinetic resolution reaction schemes described in Chapter 4. There are two types of 
Noxs: 1) nox1 catalyzes a two-electron transfer to produce hydrogen peroxide as a by-
product and 2) nox2 catalyzes a four-electron transfer to produce water as a by-product. 
This work will only involve nox 2 enzymes and there are several well-known and studied 
nox2 enzymes: L. rhamnosus [48], L. plantarum [49], L. sanfrancensis [50, 51], L. brevis 
[52-54] and S. pyogenes [55]. Noxs are flavin-dependent enzymes and protein 
engineering has been successfully performed to improve its thermostability [55] and its 
oxidative stability [49]. This thesis work will focus on the nox2 from Lactobacillus 

























1.6 Protein Engineering 
Due to wild-type enzymes being limited to a narrow range of substrates, mutations can be 
introduced with the expectation of expanding the substrate specificity. Protein 
engineering methods have rapidly improved over the years because of increased 
mechanistic, structural and sequence-based knowledge built on previous successful 
mutations. Increasing availability of crystal structures provides important structural 
information and allows for better prediction of the enzyme’s interaction with its 
substrates and catalytic mechanism. Novel protein engineering tools include iterative 
saturation mutagenesis (ISM), combinatorial active-site saturation testing (CASTing) and 
restricted libraries. ISM involves mutating individual residues within an active site to 
encompass all possible residues that may be beneficial and aims for synergistic effects 
through iteration. CASTing is a more systematic approach and chooses to saturate small 
portions of the active site based on structural knowledge. Codon restriction allows for 
focus on a small amount of target libraries with selective codon choices that allow for 
more efficient screening [56]. Accumulation of beneficial mutations mirrors the 
evolutionary path of nature but protein engineering has steadily evolved to allow for 
more efficient high-throughput screening and identification of beneficial mutations [57, 
58]. Both directed evolution and rational design have improved enzyme properties such 
as catalytic activity, substrate affinity and selectivity, and enzyme stability and both 






1.7 Map of Dissertation 
This thesis focuses on the development and application of the amine dehydrogenase for 
synthesis of chiral amines. Chapter 2 discusses the use of a biphasic organic solvent 
reaction system to allow for enzymatic conversion of hydrophobic substrates. Chapter 3 
investigates the mechanism of the amine dehydrogenase and looks to understand and 
improve its binding toward the ammonia substrate. Chapter 4 implements a kinetic 
resolution reaction of a racemic amine mixture to obtain the enantiomerically pure (S)-
enantiomer. Chapter 5 develops an aqueous two-phase extraction system for efficient 
purification of dehydrogenases. Chapter 6 summarizes the main findings in each chapter 





2DEVELOPMENT OF A BIPHASIC ORGANIC SOLVENT 
SYSTEM TO ALLOW FOR ENZYMATIC CONVERSION OF 
HYDROPHOBIC SUBSTRATES 
 
2.1 Introduction & Motivation 
Enantiomerically pure amines are commonly used as precursors for active pharmaceutical 
ingredients (APIs). The amine dehydrogenases (AmDHs) have been developed to 
catalyze the reductive amination of prochiral ketones into chiral amines with the addition 
of the cofactor NADH and ammonia. The main challenge of the newly developed amine 
dehydrogenases is their limited substrate acceptance. It is our goal to expand the range of 
substrates for AmDH towards intermediates important for pharmaceuticals or crop 
protection. The limited substrate acceptance is largely due to the hydrophobicity and thus 
low solubility of potential substrates in aqueous medium. Reactions in organic solvents 
have many advantages beyond increased solubility of substrates, including suppression of 
hydrolysis side reactions, easy product removal, and overcoming an unfavorable 
equilibrium [59, 60].  
 Biocatalytic reactions involving organic solvents often accelerate deactivation of 
enzymes. Despite this notion, many reactions have been successfully achieved, including 
amination of prochiral ketones by transaminases performed in water/DMSO [61, 62]. 
Dehydrogenases, however, have been scarcely employed in these water-miscible systems 
because of their limited stability in organic solvents, and low solubility and stability of 
the cofactor has prevented successful applications [63-65]. To incorporate biocatalysts 
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into organic solvents, work can be either performed on the biocatalyst to improve its 
stability or on the medium to optimize reaction conditions [66, 67]. Optimization of 
reaction conditions in the presence of organic solvents is the focus of the current work. 
 In biphasic aqueous-organic solvent systems, enzymes and hydrophilic cofactors, 
such as NADH, are envisioned to stay in the aqueous phase while the hydrophobic 
substrate preferentially partitions into the organic phase (Figure 2.1). Enzyme interaction 
with the organic solvent should be minimal [68]. Alcohol dehydrogenases have been used 
successfully in a biphasic reaction system coupled with cofactor regeneration using 
Candida boidinii FDH (Cb-FDH) [69, 70]. Previous work specifically involving 
phenylalanine dehydrogenases in organic solvents has included immobilization of the 
enzyme [71] or additional mutations [72] to improve stability, none of which will be 
included in this work. 
 Figure 2.1 Biphasic system reaction scheme involving F-AmDH and pFPA  
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This current work focuses on the incorporation of water-immiscible organic solvents to 
establish an efficient biocatalytic route using AmDH to produce chiral amines, often 
scaffolds for active pharmaceutical intermediates (APIs), from hydrophobic ketones. The 
substrate range for AmDH is expanded because the biphasic reaction system allows for 
conversion of desired substrates that previously could not be converted to chiral amines 
as a result of their insolubility (Figure 2.2, substrates 3 and 4). The amine products of 
pFPA (1a) and 1-adamantyl methyl ketone (3a), which is the 1-(4-fluorophenyl)-propyl-
2-amine and 1-adamantyl-ethyl-1-amine respectively, mimic APIs of sitagliptin 
(Januvia®) [73] and saxagliptin (Onglyza®) [74], respectively, two anti-Type II diabetes 
drugs. 
 
 Figure 2.2 Hydrophobic substrates of the amine dehydrogenase. 1: para-fluoro phenyl 
acetone (pFPA), 2: acetophenone, 3: 1-adamantyl methyl ketone, 4: 3-methyl-1-phenyl-2-
butanone  
 
2.2 Materials & Methods 
2.2.1 General 
Substrates were obtained from suppliers and used without further purification. NADH 
was obtained from Amresco (Solon, OH). 4-fluorophenyl acetone, 1-phenylethylamine 
and butyl acetate were obtained from Acros Organic (Morris Plains, NJ). (R/S)-1-(4-
fluorophenyl)-propyl-2-amine, 3-methyl-1-phenyl-2-butanone and imidazole were 
obtained from Alfa Aesar (West Hill, MA). Acetophenone, 1-adamantyl methyl ketone, 
 
 17
(R/S)-1-(1-adamantyl) ethylamine hydrochloride, 4-(dimethylamino)pyridine, NAD+, 
chloroform, trifluoroacetic acid (TFA) and trifluoroacetic acid anhydride (TFAA) were 
obtained from Sigma Aldrich (St. Louis, MO). Heptane and methyl-tert-butyl ether 
(MTBE) was obtained from J.T. Baker (Phillipsburg, NJ). HPLC grade methanol, toluene 
and acetonitrile were obtained from Fisher Scientific (Fairlawn, NJ). IPTG was obtained 
from Gold Biotechnology (St. Louis, MO).  
 
 
2.2.2 Protein expression and purification 
Both amine dehydrogenases were expressed in a pET-28a, BL21 (DE3) (Invitrogen) 
system at 18°C in Luria Bertani medium (United States Biological). Expression was 
induced with 0.5 mM IPTG at an OD600 value of 0.5 and continued for 12 hours. 
Overexpression was determined by observing a prominent band at 44 kDa on an SDS-
PAGE gel. His-tagged proteins were purified by employing immobilized metal affinity 
chromatography (IMAC) through a Ni-NTA resin (Thermo Scientific). Protein 
concentration is measured through Bradford assay [75]. 
 
2.2.3 Spectrophotometric and activity analysis 
Specific activity is determined using an NADH-dependent (340 nm, λ340= 6220 M-1 cm-1) 
spectrophotometric assay. Activity is calculated from the stoichiometric oxidation of 
NADH to NAD+ as measured by the change in absorbance over time. One unit of activity 
is defined as the amount of enzyme that catalyses the formation of 1 µmol of product 
amine in 1 minute. Reductive amination activity is measured in 5 M NH4/CHOO- pH 9.6 
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buffer and measured at 25°C. Protein concentration is measured through Bradford assay 
[75].  
 
2.2.4 High-performance liquid chromatography (HPLC) analysis 
Liquid chromatography was performed on a Shimadzu UFLC-2010 with a Beckman 
Coulter Ultrasphere column (4.6 mm x 25 cm). The samples are run at 1 mL min-1 with a 
column temperature at 40°C. Detection occurs at 255 nm. Methods for detecting 
conversion to amine are summarized in Table 2.1. 
 







Method MeOH-H2O-(0.5 M sodium acetate-glacial 
acetic acid, pH 3.40) 
(60:35:5) with 0.1% 
TFA [76] 
MeOH-H2O-(0.5 M sodium acetate-
glacial acetic acid, 
pH 3.40) (40:55:5) 
with 0.1% TFA [76] 
Acetonitrile (0.1% 
TFA)-water (30:70) 
r.t. ketone (min) 4.3 10.2 9.1 
r.t. amine (min) 3 3.8 3.9 
 
 
2.2.5 Gas chromatography (GC) analysis 
Gas chromatography was performed on a Shimadzu GC-2010 gas chromatography 
apparatus with a Restek Rt-BDEXcst column (length: 30 m; inner diameter: 0.32 mm; 
film thickness: 0.25 µm). 1-adamantyl methyl ketone does not absorb in the UV range so 
detection of amine was determined by gas chromatography (GC) with Flame Ionization 
Detector (FID). The reaction mixture is derivatized by trifluoroacetic acid anhydride 
(TFAA). To derivatize the compounds, 150 mM (approximately one crystal) of 4-
(dimethylamino) pyridine, which acts as a catalyst, and 2 µL of TFAA were added to 200 
µL of the sample. The derivatized sample was allowed to react for 10 minutes before GC 
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analysis. The linear velocity is 60 cm/s and the carrier gas was helium air mixture. When 
the aqueous layer was analyzed, chloroform is added to extract any leftover ketone and 
amine into the organic layer. 
 
2.2.6 Partition coefficient 
The ratio of the amount of the compound present in the organic phase compared to the 
aqueous phase was calculated to determine the partition coefficient. The aqueous medium 
is ammonium formate (5M NH4HCO2/OH pH 9.6). 25 mM of the hydrophobic substrate 
was added to the biphasic mixture. The partitioning was conducted in a glass vial 
(diameter= 0.5 cm, height= 4 cm) and allowed to equilibrate at 30°C for five hours. 
Different phase ratios were observed in a total reaction volume of 1 mL. When stirring 
was required, the sample was stirred at 150 rpm. Both the organic and aqueous layers 
were analyzed via HPLC. As for the 1-adamantyl methyl ketone, both layers were 
analyzed via GC. 
 
 
2.2.7 Conversion in purely aqueous systems (without presence of organic solvents) 
To determine conversion to the amine, reactions were performed in the presence of the 
respective amine dehydrogenase and the regeneration enzyme in a 5 mL glass vial. Time 
points were taken up to 24 hours. Only 10 mM of pFPA was added due to solubility 
issues while 30 mM of acetophenone was added into the reaction. In the case of pFPA, 
0.1 mg of F-AmDH and 0.25 mg of Cb-FDH were added to the aqueous reaction medium 
of 5 M NH4HCO2/OH pH 9.6. The reaction was performed at 35°C. In the case of 
acetophenone, 0.25 mg of cFL1-AmDH and 0.5 mg of the thermostable Bs-GDH was 
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added to the reaction medium of 5 M NH4Cl/OH pH 9.6. The reaction was conducted at 
50°C and 100 mM of glucose was added to the reaction. 1 mM NADH/NAD+ was added 
to all reactions. All reactions were stopped by diluting with methanol and analyzed using 
HPLC for amine peaks. After 24 hours, the product amine was extracted with MTBE and 
analyzed using 1H NMR (20 Hz) in CDCl3. No stirring was implemented.  
 
 
2.2.8 Biphasic conversion 
To determine conversion to the amine, reactions were performed in the presence of the 
respective amine dehydrogenase and the regeneration enzyme in a 1 mL volume and time 
points were taken. 150 mM of the substrate was added to the organic solvent. 0.1 mg and 
0.25 mg of F-AmDH was added for the pFPA and 3-methyl-1-phenyl-2-butanone 
reactions, respectively. The aqueous reaction medium was 5 M NH4HCO2/OH pH 9.6 
and the reaction was performed at 35°C. 0.25 mg of cFL1-AmDH was added to the 
reactions involving acetophenone and 1-adamantyl methyl ketone. The aqueous reaction 
medium was 5 M NH4Cl/OH pH 9.6 and the reaction was performed at 50°C. Twice as 
much regeneration enzyme activity (Cb-FDH, Bs-GDH) was added to ensure that the 
reversible reaction would not occur and that enough co-substrate NADH was always 
present during the reaction. 1 mM NADH/NAD+ was added to the reactions. All 
reactions were stopped by adding methanol and analyzed by HPLC to detect of amine 
peaks. After 24 hours, the products pFPAm and PEA were extracted with MTBE and 
analyzed via 1H NMR in CDCl3. Mass spectrometry was used to determine product 
amine with reactions involving 1-adamantyl methyl ketone and 3-methyl-1-phenyl-2-
butanone. No stirring was implemented.  
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2.3 Results & Discussion 
2.3.1 AmDH deactivation in presence of organic solvents 
The model substrate of F-AmDH is para-fluoro phenyl acetone (pFPA). pFPA has 
limited solubility (10 mM at pH 9.6 and 25°C) in aqueous ammonium formate buffer 
compared to phenylalanine due to the replacement of the carboxyl group with a methyl 
group (solubility decreases over 10-fold). The necessity to increase solubility of 
hydrophobic substrates initially led us first to monophasic aqueous-organic solvent 
reaction systems. In the presence of organic co-solvents that previously achieved success, 
including acetone, methanol, dimethyl sulfoxide (DMSO) and ethylene glycol (10-30%, v 
v-1) [77, 78], F-AmDH quickly lost most of its catalytic activity (within one minute) 
toward pFPA as compared to Candida boidinii FDH (cb-FDH) (Figure 2.3). This led to a 
transition into biphasic aqueous-organic solvent reaction systems. 
 
 Figure 2.3 F-AmDH and cb-FDH residual activity in 20% (v/v) organic solvents 




2.3.2 Partition coefficients of organic solvents and identification of heptane as the 
optimal organic solvent   
The first step towards developing a biphasic organic solvent reaction system is to identify 
potential solvents that are immiscible with water, achieved previous success [64, 69, 70], 
and exhibit minimal environmental impact to maintain benefits of biocatalysts according 
to the ACS GCI PR solvent selection guide [79]. Heptane was chosen as a representative 
example of aliphatic hydrocarbons, toluene for aromatic compounds, methyl tert-butyl 
ether (MTBE) for ethers and butyl acetate for esters [80]. Chloroform was also 
additionally chosen because of its ease of extraction of the amine product, especially 
involving analytical-scale work. Ketones were excluded because of probable cross-
reactivity as a substrate. 
According to the solvents’ log P values (Table 2.2), heptane is the least polar 
solvent (highest organic-aqueous partition coefficient) [81]. Hydrophilic solvents are 
known to remove water molecules from the surface of the enzyme essential for catalysis 
and subsequently often lead to enzyme deactivation [59]. Therefore, heptane did not 
deactivate the enzymes compared to other solvents, likely because less of it enters the 
aqueous phase [82]. In addition, we measured the log P value of pFPA in all four organic 
solvents between the aqueous reaction buffer and organic solvent (Table 2.2, Figure A.1). 
The partition coefficient of pFPA in heptane is relatively small compared to other 
solvents, so that a good portion of the substrate distributes into the aqueous phase. In 
addition, the cofactor regeneration enzyme Cb-FDH is known to have low stability in the 
presence of common water-immiscible organic solvents, such as toluene and MTBE, but 
was previously found to show stability around aliphatic hydrocarbons such as hexane and 
heptane [69, 70]. Since the enzyme may come into contact with the interface between the 
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organic and aqueous phases during the reaction, it is beneficial for the enzymes to have 
high stability in the presence of organic solvents. Heptane was ultimately chosen as the 
organic solvent for the biphasic reaction system based on these partition coefficient 
results. 
 
Table 2.2 Partition coefficient of pFPA in various organic solvents 
 Heptane MTBE Butyl Acetate Toluene Chloroform 
pFPA 1.11 2.12 2.25 2.27 2.56 
Log P values of 
solvents (reported 
in literature) a  
4.27 1.29 1.80 2.72 1.94 
aEstimated with Advanced Chemistry Development (ACD/Labs) Software V11.02 [81] 
 
2.3.3 Partition coefficient of the hydrophobic substrates and phase ratios 
Next, the partition coefficients were experimentally determined for desired hydrophobic 
substrates and their corresponding amines in heptane (Table 2.3). Larger partition 
coefficients indicate that less of the substrate moves into the aqueous phase and 
conversion becomes harder to achieve. The partition of amines is important to determine 
the ease of product extraction, and the transition of amine into the organic layer can help 
avoid product inhibition. While the partition coefficient is the most common criterion to 
predict enzyme success in organic solvents [83, 84], prediction of enzyme behavior 
within a biphasic system likely cannot be captured by just a single variable [80]. 
Enzymes can easily deactivate or perform poorly in various non-optimal reaction 




Partition coefficients are also reported here for varying phase ratios for the case of 
stirred solution (Table 2.3). Previous work in biphasic media had found the optimal phase 
ratio to be 1:4 for heptane to water [64, 69, 70]. Substrate concentration decreases with a 
smaller ratio of organic to aqueous phase because more of the substrate is partitioned into 
the aqueous phase (Figure 2.4, Figure A.2). A phase ratio of 1 to 4 is employed for the 
remaining biphasic reactions. 1-Adamantyl methyl ketone (2a) is the exception because 
the log P values are extremely skewed, as very little of the adamantyl substrate 
partitioned into the aqueous phase. Therefore, a more concentrated organic phase is 
observed. This result explains also the issue of low conversion of the 1-adamantyl methyl 
ketone to 1-(1-adamantyl) ethylamine as very little of the substrate diffuses into the 
aqueous phase regardless of the solvent.  
 
Table 2.3 Partition coefficient of substrates in heptane (a: ketone, b: amine) 
Phase ratio 1a 1b 2a 2b 3a 3ba 4a 
1:1 1.11 -0.02 1.35 -0.14 3.28 2.65 2.21 
1:2 1.12 -0.03 1.37 -0.15 3.72 2.56 2.1 
1:4 1.22 -0.1 1.35 -0.17 4.95 2.28 1.75 
1:4 stirring 1.21 -0.04 1.39 -0.18 4.94 2.36 1.79 
aAverage of two log P values: racemic 1-(1-adamantyl ethylamine) is split into two peaks 
with two retention times on the chiral GC column. For 3-methyl-1-phenyl-2-butanone 
(4a), the respective amine (α-(1-methylethyl)-benzene ethanamine)), compound 4b, is not 




 Figure 2.4 The amount of hydrophobic substrates in the aqueous layer as a function of 
phase ratio (normalized to 1a, the amount of pFPA in the aqueous phase). 
 
 
2.3.4 Effect of stirring and mass transfer limitations 
The effect of stirring on the system was also investigated. Previous biphasic reaction 
systems were gently stirred to improve distribution of the hydrophobic substrate at the 
interface [85]. However, stirring can lead to enzyme precipitation caused by shear stress. 
In addition, stirring did not show a significant difference in specific activity and is not 
critical to the overall reaction because mass transfer, as expected, is fast compared to 
kinetics. The rate limiting step of mass transfer is the movement of the substrate across 
the interface. This interfacial mass transfer occurs fast enough to ensure the reaction is 
always saturated with the adequate amount of substrate to proceed in the absence of mass 
transfer limitations (Figure A.3). The time scale for a reaction is given by Equation 2.1. 
The kcat value at 25°C and pH 9.6 for F-AmDH towards pFPA is 6.8 s-1. This reaction is 
chosen because it is the fastest reaction from ketone to amine investigated in this work 
and would be most likely to be slowed by mass transfer limitations.  
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τ = 1 k = 1 6.8 = 0.158 seconds       [Equation 2.1] 
 
The mass transfer across the interface after the system has reached steady-state is 
described by Equation 2.2. The flux of the substrate is based on the concentration 
gradient across the interface and the mass transfer coefficient in the aqueous phase. The 
mass transfer coefficient can be roughly estimated (Equation 2.3) using film theory and 
the value for the diffusion coefficient of the hydrophobic substrates in aqueous medium 
[86, 87]. The concentrations of the substrates in each phase can be estimated by the 
partition coefficients found in Table 2.3. The flux of pFPA is found to be 0.1 M·s-1, 
which shows 10 mM of the substrate can be transferred every 0.1 seconds. The KM value 
of pFPA is approximately 6 mM so at the given mass transfer rate, the enzyme will 
always be saturated with enough substrate to proceed at near maximum specific activity.  
 
J = k a C − C = 0.1 M s        [Equation 2.2]  
k = D∆x =
D
δ           [Equation 2.3]  
 
2.3.5 Impact of biphasic organic solvent system on specific activity and volumetric 
productivity  
An increased volumetric productivity is observed for pFPA and acetophenone in a 
biphasic reaction system as compared to a reaction without organic solvents (Figure 2.5). 
pFPA exhibits limited solubility (up to 10 mM) without the presence of organic solvent; 
consequently, the limit on the amine that can be produced likewise is around 10 mM in 
purely aqueous systems. However, this problem is resolved through the incorporation of 
organic solvents and the volumetric productivity doubles for pFPA and is very apparent 
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after 6 hours. Substrate conversion and thus specific activity are measured via HPLC 


































 PFPAmine (biphasic) (1b)
 1-Phenylethylamine (2b)
 1-Phenylethylamine (biphasic) (2b)
 Figure 2.5 Amount of amine product over time for pFPA and acetophenone in a biphasic 
organic solvent reaction system (A). Increased volumetric productivity over time for 
























 PFPAmine (biphasic) (1b)
 1-Phenylethylamine (2b)
 1-Phenylethylamine (biphasic) (2b)
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Specific activity of the amine dehydrogenase towards its respective substrates was 
measured over one hour. Comparable specific activity involving the model substrates is 
achieved between reaction systems with and without the presence of organic solvents 
(Table 2.4, biphasic versus monophasic). In addition, similar specific activity is observed 
between time point measurements by the HPLC and the UV-spectrometer. For highly 
hydrophobic substrates (substrates 3 to 4), specific activity can only be measured in a 
biphasic reaction system. The specific activity of cFL1-AmDH with respect to 1-
adamantyl methyl ketone is lower because very little of the substrate diffuses into the 
aqueous phase due to its high hydrophobicity. 
 
Table 2.4 Specific activity (U·mg-1), calculated over one hour (N.D.= not determined 
because of solubility issues) 
 1 2 3 4 
Biphasic (HPLC) 3.7 0.45 0.035 0.17 
Monophasic (HPLC) 4.3 0.55 N.D. N.D. 




2.3.6 Organic solvents are necessary to achieve conversion 
The amount of amine present in the system is shown to increase over time and successful 
conversion to amine is achieved for all hydrophobic substrates (Figure 2.6). A reaction 
system that does not include organic solvents cannot be used for highly hydrophobic 
substrates 3 and 4 because of little to no solubility in aqueous medium. This again 






















 1-Adamantyl methyl ketone (3a)
 3-Methyl-1-phenyl-2-butanone (4a)
 Figure 2.6 Percent conversion over time in a biphasic organic solvent reaction system  
 
 
2.3.7 Impact on enantioselectivity 
Enzymes, such as lipases can have their enantioselectivity controlled by the presence of 
organic solvents [88, 89]. Biphasic systems had no negative impact on enantioselectivity 
of the amine dehydrogenases, as compared to monophasic systems without any organic 
solvents as shown in Figure 2.7. The monophasic system produces the (R)-pFPAm with 
99.88% e.e. The biphasic system produces the (R)-amine with 99.67% e.e. in the organic 
layer and with >99.99% e.e. in the aqueous layer. With regards to the adamantyl ketone, 






 Figure 2.7 Impact of biphasic organic solvent systems on enantioselectivity: monophasic 
(a), biphasic organic layer (b) and biphasic aqueous layer (c). Chromatograms were 
obtained by GC.  
 
2.4 Conclusion 
The present work demonstrates the development of a biphasic aqueous-organic solvent 
reaction system for ketone reduction to enantiomerically pure amines catalyzed by the 
novel amine dehydrogenases and FDH/GDH for regeneration. Owing to deactivation of 
most dehydrogenases by organic solvents and low solubility of the nicotinamide cofactor, 
dehydrogenases rarely have been incorporated into water-miscible organic systems. By 
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developing  a biphasic aqueous/water-immiscible organic solvents reaction media for 
AmDH/ (FDH/GDH), we achieved two goals: i) for moderately water-soluble ketones 
substrates, we increase overall solubility and volumetric productivity, as enzymatic 
activity is comparable between aqueous and biphasic media, and ii) for highly 
hydrophobic ketones with very low water solubility, several of them reagents for APIs, 
we are able to demonstrate that they are substrates of AmDH. The results of this work 
can be applied towards further development of a biphasic organic solvent system for 



















3INVESTIGATION OF THE KM VALUE OF AMMONIA AND 
MECHANISTIC INSIGHT OF THE AMINE DEHYDROGENASE 
THROUGH RATIONAL AND PROTEIN ENGINEERING 
 
3.1 Introduction & Motivation 
All amine dehydrogenases were created by the introduction of two mutations within the 
active site of an amino acid dehydrogenase scaffold (lysine mutated to serine and 
asparagine mutated to leucine, respectively). The KM value towards ammonia of F-
AmDH significantly increased from the wild-type PheDH. The F-AmDH features a KM 
value of 557 mM towards ammonia at its optimum pH of 9.6, while the wild-type PheDH 
has a KM value of 37.6 mM. A possible reason for a decreased affinity toward ammonia 
is due to the methyl group attached to the alpha carbon instead of the carboxyl group 
[33]. This leads to a loss of the negatively charged group that attracts the partially 
positively charged ammonia at the basic pH value of 9.6. 
 A low affinity towards the ammonia substrate requires the AmDH-catalyzed 
reactions to run at ammonia concentrations greater than 2 M. At these ammonia 
concentrations, solubility of the ketone substrate decreases and there is an increased 
chance of chemical side reactions. There is also sign of substrate inhibition caused by the 
ammonia substrate. In multi-enzyme cascade reactions involving amine dehydrogenases 
paired with NADH/NAD+ cofactor regeneration enzymes (formate and glucose 
dehydrogenase, NADH oxidase), the high concentration of ammonia negatively affects 
other enzymes. In addition, the high concentration of ammonia leads to higher overall 
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cost of substrate. From a purely scientific perspective, it is important to understand the 
cause for this lower affinity for the ammonia substrate. In addition, the work in this 
chapter will also focus on developing insight into the overall mechanism of the amine 
dehydrogenases.  
 
3.2 Materials & Methods 
3.2.1 Chemicals 
Substrates were obtained from suppliers and used without further purification. NADH 
was obtained from Amresco (Solon, OH) and NAD+ was obtained from Gold 
Biotechnology (St. Louis, MO). Ammonium formate, 1-(4-fluorophenyl)-propyl-2-amine 
and L-phenylalanine were obtained from Alfa Aesar (West Hill, MA). Ammonium 
chloride was obtained from BDH Chemicals (West Chester, PA). Ammonium hydroxide 
was obtained from Ricca Chemical Company (Arlington, TX). pFPA (4-(fluorophenyl) 
acetone) was obtained from Matrix Scientific (Columbia, SC) and phenylpyruvic acid 
was obtained from Sigma Aldrich (St. Louis, MO). Cyclohexanone was obtained from 




Mutations are introduced by overlap extension PCR [90, 91] of the Bacillus badius F-
AmDH gene. The mutated gene is amplified with T7 forward and reverse primers and 
then restricted overnight with NdeI and XhoI. The gene is inserted into the pET-28a 
vector and the vector was transformed into BL21-(DE3) competent cells. Clones were 
screened for overexpression of protein. The enzyme was grown in LB medium at 30°C 
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and induced with 0.5 mM IPTG at an OD600 value of 0.5 absorbance or grown and 
expressed in Overnight Express™ EMD Millipore media at 30°C (Billerica, MA). 
Overexpression was determined by observing a prominent band at 44 kDa on an SDS-
PAGE gel. Primers and sequencing results are obtained from MWG operon (Huntsville, 
AL).  
 
3.2.2 Protein expression and purification 
AmDH were purified using the same procedure described in Section 2.2.2. 
 
3.2.3 Enzyme activity assays 
All UV-VIS analysis was performed as described in Section 2.2.3. Ammonia buffers 
were obtained by mixing solutions of ammonium hydroxide and ammonium formate at 
known concentrations to the desired pH. Unless otherwise stated, all measurements were 
performed at 25°C at pH 9.6. The ammonium hydroxide concentration was determined by 
titration with phenolphthalein.  
 
3.2.4 High throughput screening of restricted libraries 
Restricted libraries are grown in 96-well plates at 37°C and expressed at 30°C. The clones 
from the libraries are resuspended in B-PER® to lyse the cells and screened for activity at 
340 nm (NADH/NAD+ absorbance change) and 600 nm to account for any changes in the 
cell mass. The T123/D124/M125 library was screened at 500 mM, 100 mM and 50 mM 
ammonia concentrations to identify any changes in binding of ammonia substrate (Figure 
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3.1). The clones exhibiting the best activities were grown in 50 mL express media and 
purified and tested for activity.  
 
 
Figure 3.1 High throughput screening of restricted libraries 
 
 
3.3 Results & Discussion 
3.3.1 Investigation of active site residues within the amine dehydrogenase 
The kinetic mechanism of the Rhodococcus sp. PheDH has been extensively studied 
through structural analysis of the active site. The Rhodococcus sp. and Bacillus badius 
PheDH show a 32% sequence identity and 50% sequence similarity and the crystal 
structure alignment is shown in Figure 3.2. There are numerous amino acid residues 
around the active site that exhibit a charged side chain, specifically lysine and aspartate, 
which possibly affect the ammonia binding through electrostatic interactions. Studies 
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have revealed a pH dependence of the mechanism because at varying pH values there are 
changes in the kcat and KM values with respect to the substrate phenylpyruvate [92]. In 
addition, protonation of ammonia occurs at a pH values lower than its pKa value of 9.24.  
 Figure 3.2 Crystal alignment of the Rhodococcus sp. PheDH (blue) and homology model 
of Bacillus badius PheDH (green). Catalytic residues K77 and N275L are highlighted in 
red.  
 
The residue proposed to bind to ammonia in the Rhodococcus sp. PheDH is the 
negatively charged aspartate at position 118. The corresponding amino acid in the 
Bacillus badius PheDH is aspartate 124 and is suspected to have favorable electrostatic 
and hydrogen bonding interactions with the free ammonium [92, 93] (Figure 3.3). A 
single mutation was introduced at that position to introduce another negatively charged 
residue glutamate to check if activity could be retained. However, this mutation 
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decreased the activity of enzyme by 100-fold and did not change the KM value of 
ammonia. Glutamate is a larger residue and could have posed steric constraints on the 
binding pocket [data not shown]. Therefore, it is hypothesized that aspartate 124 is not 
directly responsible for the binding of ammonia.  
 
 Figure 3.3 Proposed binding mechanism of ammonia in Rhodococcus sp. PheDH [92] 
  
A restricted library was performed simultaneously at T123/D124/M125 on the F-AmDH. 
The following codons were implemented to allow for efficient screening: T123MVT, 
D124VAW and M125ADK. 768 colonies were expressed and screened for activity at 500 
mM, 100 mM and 50 mM concentrations of ammonia to see if any mutations would have 
an impact on the binding of ammonia. 20 clones exhibiting the best activities were 
purified but no improvement in activity or binding of ammonia was observed. None of 
the clones contained any mutations at the D124 and M125 residue and only glycine and 
asparagine mutations were found in the T123 residue. All additional site-specific 
mutations performed on the active site of the F-AmDH are located in Appendix B.  
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3.3.2 Incorporation of lysine into active site to improve electrostatic interactions 
As previously mentioned, the amine dehydrogenase (AmDH) exhibits roughly a 20 times 
fold decrease in binding for the ammonia substrate as compared to the amino acid 
dehydrogenase (aaDH). The two main differences between the AmDH and aaDH are 1) 
loss of the positive charge with the lysine to serine mutation (on residue 77) and 2) loss 
of the carboxylic group (negatively charged group) in the substrate. It was hypothesized 
that another positively charged lysine residue plays a role in the binding of ammonia and 
further investigation is performed on lysine residue 89. The lysine 66 and 78 residues of 
the Rhodococcus sp. PheDH (as shown in Figure 3.4) align with lysine 77 and 89 of the 
Bacillus badius PheDH.   
 
 
 Figure 3.4 Amino acids within active site of the Rhodococcus sp. PheDH [93] 
 
The K89S mutation was introduced into the Bacillus badius phenylalanine 
dehydrogenase. As shown in Table 3.1, the activity was dramatically decreased over a 
1000 times fold (25 compared to 0.017 U/mg). However, when that same mutation is 
 
 39
introduced into the F-AmDH, the activity decreased just over 1.5 times (5.5 compared to 
3 U/mg). This indicates a possible difference in the mechanism between the two 
enzymes, since the introduction of the K89S mutation shows very different results with 
regards to catalytic activity for both enzymes. Furthermore, the K89S mutations 
drastically decreased the binding of ammonia of the F-AmDH (KM > 1.5 M). It was 
hypothesized that this lysine residue was not necessarily important for catalytic activity 
but instead critical for the binding of ammonia. It was further hypothesized that 
additional lysine residues within the active site would improve electrostatic interactions 
and increase the F-AmDH binding toward its ammonia substrate.  
 
Table 3.1 K89S variants on the B. badius F-AmDH and the PheDH 
 pFPA (U/mg) L-Phe (U/mg) 
PheDH Not active 25 
K89S Not active 0.017 N275L 0.13 0.023 
K89S/N275L 0.024 0.0006 
K89S/K77S 0.065 Not active 
K89S/K77S/N275L 3 Not active 
F-AmDH (K77S/N275L) 5.5 Not active 
 
 
As shown in Table 3.2, lysine residues were individually incorporated into the active site 
to replace twelve amino acid residues and the affinity for ammonia and catalytic activity 
was measured. Not only did the lysine residues not improve the binding toward the 
ammonia substrate, the introduction often made it worse. In addition, lysine at residue 77 
was introduced back into the F-AmDH (K77K/N275L) and the binding toward ammonia 
did not improve. Furthermore, when lysine was introduced at residue 275 
(K77S/N275K), the binding toward ammonia dramatically decreases (KM > 1.5 M) 
(Figure 3.5). This data, along with the variants listed in Table 3.2, leads to the conclusion 
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that the introduction of additional lysine into the active site of the F-AmDH does not help 
the binding to the ammonia substrate.  
 
Table 3.2 Lysine mutations within the active site of the B. badius F-AmDH. All activity 
was measured in 5 M NH4OH/CHOO- buffer at 25°C. 
Mutation Effect on KM value of ammonia  Effect on specific activity  G50K Did not express N/A 
G51K Not active N/A 
R53K Worsen (>1.5 M) No change 
Y76K No change No change 
D82K No change 1/4 less active 
G88K Did not express N/A 
G122K Not active N/A 
T123K Worsen (>1.5 M) 1/4 less active 
D124K Not active N/A 
D131K Worsen (>1.5 M) 2/3 less active 
S155K Not active N/A 




 Figure 3.5 Mutation of lysine back into the active site of the F-AmDH 
 
3.3.3 Equilibrium constant of the F-AmDH 
An estimate of the equilibrium constant of the F-AmDH was determined to gain further 
insight on the reaction mechanism. The reaction of the F-AmDH is reversible, as shown 
in Figure 1.4 and Figure 1.5. The equilibrium constant represents the ratio of the 
concentration of the reactants to products at equilibrium and is described by Equation 3.1. 
The true equilibrium constant must also take into account the proton released during the 




K = [NADH][4 − flurophenylacetone] NH[NAD ][1 − 4 − fluorophenyl propyl − 2 − amine]       [Equation 3.1]  
 
Brunhuber et al. determined the Keq of the Rhodococcus sp. phenylalanine dehydrogenase 
by monitoring the amount of NADH that is present once equilibrium is reached and then 
determining the concentration of each substrate [92]. Once the NADH concentration does 
not change, the forward and reverse reactions are moving at the same rate. It is important 
that in the reaction conditions, all substrates are in equimolar quantities as to not drive the 
reaction past equilibrium (La Chatelier’s principle). Due to the high KM value of 
ammonia, at least 50 mM of ammonia must be added to the reaction to observe catalytic 
activity. In addition, ammonia had to be added in the oxidative deamination direction 
because the amount of ammonia released from pFPAm is not enough to drive the 
reaction. 200 µM NADH, 200 µM pFPA and 50 mM ammonia were added for the 
reaction in the forward direction; 200 µM NAD+, 400 µM pFPAm (because of racemic 
mixture) and 50 mM ammonia were added in the reverse direction. The change in 
absorbance on the UV-VIS is shown in Figure 3.6 (red/green lines represents reductive 
amination direction and blue/purple lines represents oxidative deamination direction).  
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 Figure 3.6 Equilibrium constant determination of the F-AmDH. Reductive amination 
activity was performed in 5 M NH4OH/CHOO- buffer pH 9.6 and oxidative deamination activity performed in 0.1 M glycine pH 10.4 at 25°C. 
 
 
The Keq in the reductive amination direction was calculated to be 3.89 x 10-9 M2. The Keq 
in the oxidative deamination direction was calculated to be 1.52 x 10-9 M2. The 
differences in the equilibrium constants are probably due to the fact that ammonia had to 
be added in the oxidative deamination direction to obtain any catalytic activity. For the 
Rhodococcus sp. phenylalanine dehydrogenase, the Keq was 4.5 x 10-14 M2, which is 
typical of other amino acid dehydrogenases [92, 94]. The difference in the equilibrium 
constants between the AmDH and aaDH is due to the high amount of ammonia that must 
be present in order for reaction to occur. In both cases, the equilibrium constant value is 







3.3.4 Hammett correlation  
The substrate profile of an enzyme can help to determine the mechanism of any enzyme. 
The transaminase has a dual substrate recognition active site that impacts its substrate 
range and mechanism [19, 20, 95]. The Hammett correlation on various substituents on 
the phenyl ring of acetophenone was investigated for the chimeric amine dehydrogenase 
(Table 3.3). The data was fit to each substrate’s sigma, hydrophobic and steric 
parameters. There was no correlation for these substrates, as shown in Figure 3.7. 
 
Table 3.3 Impact on activity with various substituents on phenyl ring of acetophenone 
Substrate Vmax (U/mg) KM-ketone (mM) Acetophenone 0.4 1.93 
4-methoxy 0.016 14.2 
4-chloro 0.31 6.88 
4-nitro Not active N/A 
4-acetobenzylnitrile 0.036 12.16 
4-methyl 0.21 7.62 
4-amino 0.079 N/A 
4-dimethyl amino Not soluble N/A 
4-methyl sulphonyl Not active N/A 






 Figure 3.7 Hammett correlation of the cFL1-AmDH with respect to (A) sigma, (B) 
hydrophobic and (C) steric parameters. Acetophenone (dark blue), 4-methoxy (orange), 






3.3.5 Mechanistic insight of the amine dehydrogenases 
In the reductive amination direction, the amine dehydrogenase reaction represents a 
terreactant mechanism with three substrates- NADH, pFPA and ammonia. The initial 
velocity is collected at various concentrations of the three substrates (A and B but at a 
fixed concentration of C; at various concentration of A and C but a fixed concentration of 
B; and at various concentrations of B and C but at a fixed concentration of A) as shown 
in Figure 3.8 through 3.10. Measurements are performed around the KM value and as 
close to saturation as possible with respect to each substrate. The data was fit to the 
Michaelis-Menten equation using non-linear regression analysis through KaleidaGraph 











 Figure 3.8 Lineweaver-Burk plots of concentration of pFPA versus velocity at (A) 
various fixed concentrations of ammonia: 5 M (dark blue), 2 M (red), 1M (green), 500 
mM (purple), 250 mM (light blue), 100 mM (orange) at 200 µM NADH concentration 
and (B) various fixed concentrations of NADH: 200 µM (dark blue), 100 µM (red), 50 µM (green) and 25 µM (purple) at 2 M ammonia concentration. Converging lines indicate 
sequential mechanism. Data was fit to Equation 3.3 and best fit parameters are listed in 









 Figure 3.9 Lineweaver-Burk plots of concentration of ammonia versus velocity at (A) 
various fixed concentrations of NADH: 200 µM (dark blue), 100 µM (red), 50 µM 
(green), 25 µM (purple) at 10 mM pFPA concentration and (B) various fixed 
concentrations of pFPA: 10 mM (dark blue), 5 mM (red), 2.5 mM (green), 1.25 mM 
(purple) and 1 mM (black) at 200 µM NADH concentration. Converging lines indicate 
sequential mechanism. Data was fit to Equation 3.3 and best fit parameters are listed in 









 Figure 3.10 Lineweaver-Burk plots of concentration of NADH versus velocity at (A) 
various fixed concentrations of pFPA: 10 mM (dark blue), 5 mM (red), 2.5 mM (green) 
and 1.89 mM (purple) and 1.25 mM (light blue) at 200 µM NADH concentration and (B) 
various fixed concentrations of ammonia: 2 M (dark blue), 1 M (red), 500 mM (green), 
375 mM (purple) and 250 mM (light blue) at 10 mM pFPA concentration. Parallel lines 
indicate ping pong mechanism. Data was fit to Equation 3.3 and best fit parameters are 





With the exception of the Lineweaver-Burk plots employing varying concentrations of 
NADH at different fixed concentrations of ammonia and pFPA (Figure 3.10), all double 
reciprocal plots of velocity versus substrate concentration demonstrate a converging 
pattern indicative of a sequential mechanism. This is similar to results obtained in 
literature for the wild-type B. badius PheDH [96]. Parallel lines are indicative of a ping 
pong component to the mechanism. A terreactant reaction mechanism is described by 
Equation 3.2 [97-99] (substrate A= NADH, B=pFPA, C=ammonia). ‘V’ represents the 
maximum velocity and KA, KB and KC are Michaelis-Menten constants observed when 
all other substrates are at saturation. The equation is fitted to the data in the reductive 
amination direction with F-AmDH and pFPA (fitting performed by Robert D. Franklin in 
Mathematica). 
 
= Vconst + coefA + coefB + coefC + K + K + K +       [Equation 3.2]  
The best fit of the data presented in Figure 3.8 through Figure 3.10 to Equation 3.2 show 
the coefficients terms of the pFPA (B) and ammonia (C) are not statistically different 
from zero and are therefore determined to be missing, leading to the data to be fit to 
Equation 3.3 instead. The values of the respective parameters from this best fit are listed 
in Table 3.4. This suggests a sequential mechanism with steady-state addition of NADH 
first to the enzyme followed by a random addition of pFPA and ammonia. This 
mechanism is similar to a citrate cleavage enzyme [100]. The theoretical Vmax value of 
37.86 U/mg is never reached because the enzyme becomes inhibited before it can reach 
saturation (especially with respect to the ammonia substrate) and the ketone becomes 
insoluble before it can reach full saturation. Saturation of ammonia and pFPA cannot be 
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achieved under experimental conditions. As a result, the KM value listed is higher than 
the apparent KM value measured because this equation is fitted with respect to all three 
substrates and therefore is more accurate by taking into account any substrate or product 
inhibition. 
 
= Vconst + coefA + K + K + K +       [Equation 3.3] 
  
 
Table 3.4 Coefficients of the F-AmDH/pFPA reductive amination reaction (R2= 0.9597). 
A=NADH, B=pFPA, C=ammonia 
Coefficients Value 
V (U/mg) 37.86 ± 8.89 
const 470.6 ± 124.18 
coefA 14913 ±3372.98 
KA(mM) 0.114 ± 0.032 KB (mM) 22.35 ± 6.56 KC (mM) 1798 ±675.18  
The same experiments were performed in the oxidative deamination direction as shown 
in Figure 3.11. In the oxidative deamination direction, the amine dehydrogenase reaction 
represents a bireactant mechanism with two substrates- NAD+ (A) and pFPAm (B). The 
data was fit to Equation 3.4, indicating a sequential reaction (fitting performed by Robert 
D. Franklin in Mathematica). It cannot be concluded if the binding is ordered or random 
until inhibition studies have been completed. The values are listed in Table 3.5.  
 





Table 3.5 Coefficients of the F-AmDH/pFPAm oxidative deamination reaction 
(R2=0.9899) 
Coefficients Value 
V (U/mg) 0.827 ± 0.029 
























 Figure 3.11 Lineweaver-Burk plots of (A) various concentrations of NAD+ versus 
velocity at various fixed concentrations of pFPAm: 10 mM (dark blue), 5 mM  (red), 2.5 
mM (green), 1 mM (purple) 0.5 mM (light blue) and (B) various concentrations of 
pFPAm versus velocity at various fixed concentrations of NAD+: 200 µM (dark blue), 
100 µM (red), 50 µM (green), 25 µM (purple), 10 µM (light blue). Data was fit to 









3.3.6 Chemical reaction of substrates in the presence of ammonia 
There is a drastic difference in the binding of ammonia in the amine dehydrogenase 
reaction compared to the amino acid dehydrogenase reaction. It is hypothesized that the 
difference may be attributed not to any changes to the enzyme but rather to the substrate 
itself (ketone versus keto acid). When acetophenone (substrate of the chimeric amine 
dehydrogenase reaction) is placed in the presence of high concentration of ammonia (up 
to 5 M), no chemical interaction that leads to a new intermediate is observed through 
carbon NMR. There is no presence of a tetrahedral intermediate or imine formation and 
the spectrums are nearly identical (Figure 3.12).  
 Figure 3.12 Acetophenone in the presence of 5 M ammonia pH 9.0 (A), 5 M ammonia 
pH 11.0 (B) and water (C).  
 
 
Next, phenyl pyruvic acid was placed in 100 mM ammonia buffer. Shifts in the carbon 
NMR spectrum are detected and the presence of a tetrahedral intermediate and imine are 






205 ppm in the ammonia buffer (assignments of the peaks are difficult because no 
experimental spectrum of the isolated imine or tetrahedral intermediate have been 
reported). It is hypothesized that the presence of more electron withdrawing groups 
attached to the methyl group would allow for the formation of an imine or tetrahedral 
intermediate (Figure 3.14). The enzyme can then convert the imine intermediate into an 
amine. 2-chloro-acetophenone was tested for activity as an example of a more electron 
withdrawing group on the methyl but cFL1-AmDH does not show any activity (although 
no activity could also be attributed to a chemical reaction of 2-chloro-acetophenone in the 
presence of high ammonia concentrations).  
 
 
Figure 3.13 Phenyl pyruvic acid in the presence of water (A) and 100 mM ammonia pH 
9.6 (B) 
A 
B 45 ppm 
100 ppm 
205 ppm 170 ppm 
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 Figure 3.14 Hypothesized formation of tetrahedral intermediate and imine 
 
 
3.3.7 pH dependence profiles of the amine dehydrogenases  
The affinity towards ammonia was measured in various buffer conditions. Different 
ammonia buffers (formate, chloride, acetate, bicarbonate, data located in Figure C.1) and 
various substituents on the phenyl ring of the ketone (Figure C.2) influenced the specific 
activity but did not change the affinity toward the ammonia substrate. However, different 
KM values towards ammonia were observed at various pH values (Table C.3) and further 
investigation was needed.  
 The enzymatic activity of the F-AmDH towards pFPA was measured at various 
pHs and the data was fitted to the double ionization model [101] (Equation 3.5) using 
KaleidaGraph (version 3.5.2). The pKa of the reaction is obtained from fitting this 
equation. ‘y’ is kcat or kcat/KM, ‘C’ is the pH-independent value of y, which in this case is 
the maximum value of kcat or kcat/KM, H is [H+] and K1 and K2 represent the dissociation 




log y = log C/ 1 + +               [Equation 3.5]   
 
The kcat (orange curve) and kcat/KM (red curve) are shown in Figure 3.15. The same curve 
trend is observed, which indicates the same ionizable group contributes to both catalysis 
and the binding of ammonia. This result indicates that to improve the binding of 
ammonia (to either the active site or the ketone) surrounding residues (not the catalytic 
residue) need to be mutated to maintain the desired protonation state. An identical trend 
was observed with another ketone substrate of the F-AmDH with lower specific activity, 
cyclohexanone (Figure 3.16). Table 3.6 lists the pKa1 value of around 7.5 and the pKa2 
value of around 11. A cysteine or histidine residue is suspected to be responsible for 
pKa1 and a lysine residue is responsible for pKa2. The lysine residue is suspected to be 
the lysine at position 77 for the F-AmDH. In addition, the same experiment was 
performed with the wild-type Bacillus badius phenylalanine dehydrogenase and fit to a 
double ionization model (Figure 3.17). Interestingly, a higher pKa1 value of 8.82 is 
observed compared to the F-AmDH (Table 3.6). This difference could be indicative of an 





 Figure 3.15 Double ionization models to describe pH dependence of F-AmDH/ pFPA, 
kcat (orange curve), kcat/KM (red curve). Activity was measured in NH4OH/CHOO- buffer at 25°C.  
 
 
 Figure 3.16 Double ionization models to describe pH dependence of F-AmDH/ pFPA 
(red curve) versus F-AmDH/ cyclohexanone (grey curve). Activity was measured in 

















 Figure 3.17 Double ionization models to describe pH dependence of F-AmDH/ pFPA 
(red curve) versus WT PheDH/ phenyl pyruvic acid (blue curve). Activity was measured 
in NH4OH/CHOO- buffer at 25°C.  
 
Table 3.6 pKa1 and pKa2 values of the B.badius F-AmDH and PheDH reactions 
 Substrate Enzyme pKa1 pKa2 
kcat pFPAcetone F-AmDH 7.44 ± 0.139 10.99 ± 0.185 kcat/KM pFPAcetone F-AmDH 7.78 ± 0.134 10.96 ± 0.185 kcat/KM phenylpyruvic acid PheDH 8.82 ± 0.192 10.89 ± 0.279  
 
3.4 Conclusion 
The F-AmDH exhibits a significantly decreased affinity for ammonia than the amino acid 
dehydrogenase. Mutations within the active site did not improve the binding of the 
ammonia substrate. The activity of the AmDH was tested in various buffer conditions and 
substrate concentrations in order to determine its mechanism. Results from initial rate 
studies indicate the steady-state addition of NADH followed by the random addition of 








reaction to form the imine (ammonia and ketone) before proceeding to enter the active 
site of the enzyme. In addition, pH studies suggest that a cysteine or histidine residue 
likely contributes to the binding of ammonia and future work should focus on mutating 





4EXTENDING THE UTILITY OF THE AMINE 
DEHYDROGENASE: SYNTHESIS OF THE (S)-AMINE THROUGH 
KINETIC RESOLUTION 
 
4.1 Introduction & Motivation 
Kinetic resolution of amines has been extensively studied in the literature and offers a 
viable alternative when asymmetric synthesis is not possible. Transaminase and amine 
oxidases are widely known for their enzymatic production of chiral amines. Numerous 
accounts of kinetic resolution of racemic chiral amines have been successfully achieved 
through ω-transaminases [102-106] and monoamine oxidases [107-110]. For example, ω-
transaminase has been used for deracemization of mexiletine, an intermediate for an 
analgesic oral drug [23]. In addition, dynamic kinetic resolution of ibuprofen to obtain 
the (S)-enantiomer has been described in the literature [7].  
 The recently developed amine dehydrogenase (AmDH) class of enzymes shows 
extremely high enantioselectivity for production of (R)-amines (>99% e.e.) from 
prochiral ketones [32-34, 111]. So far, no success of switching the enantioselectivity of 
the AmDH has been achieved through protein engineering within the active site. As a 
result, we turn to kinetic resolution of the racemic amine mixture to obtain the 
enantiomerically pure (S)-amine (Figure 4.1). The amine dehydrogenase reaction is 
reversible, making it an ideal candidate for enantiomerization reactions. 
 Regeneration of NAD+ from NADH is afforded by coupling the AmDH reaction 
with the NADH oxidase-catalyzed reduction of molecular oxygen to water [50, 52]. In 
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the present work, racemic amine substrates of 1-phenylethylamine (1), 1-(2-
napthyl)ethylamine (2), 2-aminohexane (3), 1,3-dimethylbutylamine (4) and 3,3-
dimethyl-2-butylamine (5) were successfully deracemized to obtain their respective (S)-
amine (Figure 4.2). 
 Figure 4.1 Kinetic resolution reaction scheme by the amine dehydrogenases 
 
 
 Figure 4.2 Production of (S)-enantiomer through oxidative deamination of racemic 




4.2 Materials & Methods 
4.2.1 Chemicals 
Chemicals were obtained from suppliers and used without further purification. 
Acetophenone, methyl isobutyl ketone, (R/S)-1,3-dimethylbutylamine, (R)-
phenylethylamine, chloroform and 4-(dimethylamino) pyridine were obtained from 
Sigma Aldrich (St. Louis, MO). (R/S)-1-phenylethylamine (1-PEA) and HPLC grade n-
hexane were obtained from Acros Organic (Morris Plains, NJ). (R)-(+)-1-(2-
napthyl)ethylamine, (S)-(-)-1-(2-napthyl)ethylamine, 2-acetylnapthalene, (R)-2-
aminohexane, (R)-3,3-dimethyl-2-butylamine and  (R/S)-3,3-dimethyl-2-butylamine were 
obtained from Alfa Aesar (Ward Hill, MA). (R/S)-2-aminohexane was obtained from 
Pfaltz and Bauer (Waterbury, CT). 2-hexanone and 2-pinacolone were obtained from 
Aldrich Chemical Company (Milwaukee, WI). NADH was obtained from Amresco 
(Solon, OH). NAD+ and dithiothreitol (DTT) were obtained from Gold Biotechnology (St. 
Louis, MO). Isopropanol was obtained from Fisher Scientific (Fairlawn, New Jersey).  
 
4.2.2 Protein Expression and Purification 
AmDHs were purified using the same procedure as described in Section 2.2.2. NoxV and 
the K147R variant were expressed in a pET-28a, BL21 (DE3) (Invitrogen) system at 
30°C in Overnight ExpressTM Instant TB medium (Novagen). NoxV was expressed and 
purified based on a protocol previously described [49]. Cell pellets were resuspended in 
50 mM Tris-Cl buffer pH 7.5 with 5 mM DTT (Buffer A). The suspension was sonicated 
at 14 W for 1 minute ten times. Sonicated cells were centrifuged at 10,000 rpm for 30 
minutes. The clarified cell lysate was subjected to 50% ammonium sulfate precipitation. 
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The supernatant was filtered through a 0.8 µm microfiltration membrane (Pall 
Corporation, Ann Arbor, MI) and loaded onto a HiPrep 16/10 butyl hydrophobic column 
on an AKTAexplorerTM. A gradient separation was performed starting from Buffer A 
with 50% ammonium sulfate decreasing down to 15%. The fractions with highest activity 
were collected and dialyzed against 50 mM Tris-Cl buffer pH 7.5 with 5 mM DTT 
(Buffer A). The sample was loaded onto a HiPrep 16/10 DEAE anionic exchange column 
on an AKTAexplorerTM. A gradient separation was performed starting from buffer A 
with 150 mM NaCl increasing up to 250 mM NaCl. The fractions with highest activity 
were collected as pure protein. The purification yield is shown in Table 4.1 and the SDS-
PAGE gel is shown in Figure 4.3.  
 
Table 4.1 Purification of L. plantarum NADH oxidase (NoxV) 
 Volume (mL) Protein (mg) S.A. (U.mg-1) Yield (%) 
Cell lysate 15 164.4 5.89 100 
50% (NH4)2SO4 7.5 94.2 5.07 48.7 Butyl HIC 40 14 14.1 20.4 





 Figure 4.3 Purification of L. plantarum NADH oxidase (SDS-PAGE gel) 
 
4.2.3 Spectrophotometric and activity analysis 
All analysis was performed as described in Section 2.2.3. 
 
4.2.4 High-performance liquid chromatography (HPLC) analysis 
Liquid chromatography was performed on a Shimadzu UFLC-2010 with a Daicel 
Chiralpak AS column to separate 1-(2-napthyl)ethylamine. Its enantiomers do not 
separate on the GC. The samples are run at 1 mL min-1 with column temperature at 25°C. 
Detection occurs at 225 nm and 1 µL of sample was injected. The mobile phase was a 
gradient mixture of n-hexane and isopropanol with 0.1% diethylamine (DEA) (from 5% 
to 20% of isopropanol). The reaction mixture was diluted with isopropanol and filtered 










4.2.5 Gas chromatography (GC) analysis 
Gas chromatography was performed on a Shimadzu GC-2010 gas chromatography 
apparatus with an Astec CHIRALDEXTM B-DM column (length: 30 m; inner diameter: 
0.25 mm; film thickness: 0.12 µm). The compounds are extracted into organic solvent 
chloroform from the aqueous reaction mixture. The reaction mixture is derivatized by 
trifluoroacetic acid anhydride (TFAA). To derivatize the compounds, 1.5 µL of 1 M 
solution of 4-(dimethylamino) pyridine in chloroform, which acts as a catalyst, and 1.5 
µL of TFAA were added to 200 µL of the sample. The derivatized sample was allowed to 
react for 10 minutes before GC analysis. The linear velocity was 60 cm/s and the carrier 
helium air mixture.  
 
4.2.6 Oxidative deamination reaction conditions 
Reactions were performed in 0.1 M glycine buffer pH 8.0 in a total volume of 1.5 mL.  
All reactions were conducted at 35°C, except for the 1-(2-napthyl)ethylamine/cFL1-
AmDH reaction which was performed at 45°C. 20 mM of racemic amine mixture of 1-
PEA (substrate 1) was added to the reaction. 10 mM of racemic amine mixture was added 
of the amine substrates 2 through 5. 10 mM DTT is added into all reactions. No stirring is 
implemented. 
 6 U of the AmDH is added into the reaction to 1 U of the NADH oxidase. 20 mM 
NAD+ is added into the reaction mixture. After 24 hours of reaction, an additional 4 U of 
AmDH and 20 mM NAD+ were added to the reaction to drive it to completion and 
stopped after 36 hours. For the 1,3-DMBA/L-AmDH reaction, an additional 10 mM 
NAD+ was added and the reaction was left for an additional 4 hours to obtain full 
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conversion (40 hours total). For the 1-(2-napthyl)ethylamine/ cFL1-AmDH reaction, 20 
mM NAD+, 1.5 U of cFL1-AmDH and 1 U of NADH oxidase was added to the reaction. 
1 U of cFL1-AmDH/ 20 mM NAD+ was added at 24 hours and 1 U of cFL1-AmDH/ 10 
mM NAD+ was added at 36 hours to drive the reaction to completion (48 hours total). 
 
4.3 Results & Discussion 
4.3.1 Protein engineering to improve oxidative deamination activity 
The use of protein engineering to improve oxidative deamination activity of the AmDHs 
was investigated. The same two catalytic residues are responsible and essential to create 
amine dehydrogenase activity: L-AmDH (K67/N260) [32], F-AmDH (K77/N275) [33], 
cFL1-AmDH (K77/N270) [34]. Mutation of the lysine to a serine and the asparagine to a 
leucine was the top variant for reductive amination activity for all amine dehydrogenases. 
It was hypothesized that different amino acid residues are optimal for the desired reverse 
reaction, the oxidative deamination reaction. Reducing reductive amination activity is 
also crucial to prevent the reverse reaction from the ketone back to the amine and assist in 
the equilibrium of the reaction. Mutation of that catalytic lysine to methionine and 
asparagine to valine, respectively, created the top variant for oxidative deamination 
activity for all three AmDHs (mutations to the L-AmDH were previously performed [32]) 
(Table 4.2). The most dramatic improvement was observed for the cFL1-AmDH: relative 
oxidative deamination towards 1-phenylethylamine (1) was increased 10-fold, while 










L-AmDH (K67S/N260L) a) 0.46 1.76 
L-AmDH (K67M/N260V) a) 0.059 1.87 
F-AmDH (K77S/N275L) b) 3.19 1.39 
F-AmDH (K77M/N275V) b) 1.23 1.70 
cFL1-AmDH (K77S/N270L) c) 0.3 0.066 
cFL1-AmDH (K77M/N270V) c) 0.044 0.52 
a) Activity toward L-AmDH substrate, methyl isobutyl ketone and 1,3-
dimethylbutylamine [32]; b) Activity toward F-AmDH substrates, para-fluoro phenyl 
acetone (pFPA) and para-fluoro phenyl amine;. c) Activity toward cFL1-AmDH 
substrates, acetophenone and 1-phenylethylamine; d) Reductive amination activity was 
performed in 5 M NH4OH/CHOO- buffer pH 9.6 and oxidative deamination activity performed in 0.1 M glycine pH 10.4 at 25°C.  
 
 
 Figure 4.4 Impact of amino acid changes at catalytic residues in L-AmDH (blue), F-
AmDH (red) and cFL1-AmDH (green) 
 
4.3.2 Protein engineering to improve thermostability of the NADH oxidase 
Cofactor recycling of NADH/NAD+ is performed through Lactobacillus plantarum 
NADH oxidase (NoxV). Previous characterization of the NoxV showed a Topt of 40°C 
and loss of enzyme activity after just 2 hours at room temperature [49]. Protein 
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engineering to improve temperature stability was performed in hopes to achieve optimal 
reaction conditions. Lysine residues mutated to arginine residues often show improved 
protein stability [112]. Recent work on S. pyogenes NADH oxidase showed that a single 
point mutation K184R improved activity by 50% and improved thermostability by 
increasing the half-life at 30°C by 46.6% [55]. Sequence alignment showed that this 
surface lysine is conserved among several NADH oxidases. The K147R mutation was 
introduced to the L. plantarum NoxV and the variant maintained 100% activity after 6 
hours, compared to 2 hours for the wild-type. In addition, the enzyme retains 67% of 
activity after 22 hours. However, the specific activity and optimum temperature of K147 
variant of NoxV did not improve (Figure 4.5).  
 
 Figure 4.5 Temperature stability of NoxV (K147R) at room temperature 
 
 
4.3.3 Determination of kinetic parameters in oxidative deamination reactions 
The oxidative deamination reaction has been less thoroughly investigated compared to 
the reductive amination direction. To ensure optimal oxidative deamination reaction 
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conditions of the racemic amine mixtures, kinetic parameters were obtained via UV-VIS 
spectrometry (Table 4.3). Specific catalytic activity was measured toward the ketone and 
amine substrates and the KM value toward the amine substrate was determined.  The 
MIBK/1,3-DMBA (4) was the only reaction which utilized the methionine/valine variants 
described in the previous section.  
 Despite substantial improvements in increasing the oxidative deamination activity 
of the cFL1-AmDH (as previously described and shown in Table 4.2 and Figure 4.4), L-
AmDH was chosen instead as the enzyme for 1-PEA to acetophenone activity due to its 
surprisingly higher activity toward 1-PEA and better temperature optimum  (Table 4.4). 
L-AmDH unexpectedly displays 10-fold lower activity in the reductive amination 
direction towards acetophenone, which is highly beneficial for the desired oxidative 
deamination reaction. Furthermore, L-AmDH displays little activity toward pinacolone 
(0.054 U/mg) but displays around 25 times more activity in the oxidative deamination 
direction (1.43 U/mg, Table 4.4). These interesting but unexpected results of L-AmDH 
catalytic activity toward the amine but not toward the respective ketone will be further 
investigated in future work.  
 (R)-1-(1-napthyl)ethylamine is the active pharmaceutical ingredient for Sensipar® 
(Cinacalcet) [113] and a desired target substrate for the AmDHs. cFL1-AmDH does not 
show any activity toward the (R)-1-(1-napthyl)ethylamine but it does exhibit 0.205 U/mg 
of enzymatic activity towards the (R)-1-(2-napthyl)ethylamine. This is due to the position 
of the amine group relative to the aromatic ring. No activity was observed for the 
respective (S)-enantiomer making it an ideal candidate for this reaction. The double 
variant K77M/N270V showed no improvement in the oxidative deamination activity over 
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cFL1-AmDH (K77S/N270L). In addition, F-AmDH showed no activity toward either 
substrate, once again displaying the difference in substrate profiles between the two 
enzymes. 
 Additionally, despite being an aliphatic substrate, F-AmDH unexpectedly displays 
higher activity toward 2-aminohexane than L-AmDH (1.59 versus 0.93 U/mg, 
respectively). The same trend was observed with the ketone substrates 2-hexanone and 2-
octanone. F-AmDH may be more accepting of these larger aliphatic substrates because its 
model substrates traditionally consist of a bulky phenyl ring and therefore, it is more 
accommodating to larger substrates.   
 
Table 4.3 Kinetic parameters of the AmDHs in their respective reactions 
Reaction Acetophenone/ 
 1-PEA (1) 
2-acetylnapthalene/ 1-(2-
napthyl) ethylamine (2) 
2-hexanone/  
2-aminohexane (3) 





S.A. (Amination) 0.059 0.011 0.38 
S.A. (Deamination) 0.97 0.205 1.59 






Table 4.4 Activity of L-AmDH and various AmDHs towards acetophenone/1-PEA 
 Reductive amination of 
acetophenone (U/mg) 
Oxidative deamination 
of (R)-1-PEA (U/mg) 
Temperature 
optimum (°C) 
L-AmDH (K67S/N260L) 0.059 0.97 50 F-AmDH (K77S/N275L) <0.1 0.019 50 cFL1-AmDH (K77S/N270L) 0.3 0.066 >80 cFL1-AmDH (K77M/N270V) 0.044 0.52 >80 a) S.A.: specific activity (U/mg).  b) Reductive amination activity was performed in 5 M NH4OH/CHOO- buffer pH 9.6 and oxidative deamination activity performed in 0.1 M glycine pH 10.4 at 25°C. 
 
 Cofactor inhibition ratios of the L-AmDH/NoxV were investigated. L-AmDH displays a 
KM value at 40.56 µM towards NAD+ and KI at 259.5 µM towards NADH. Competitive 
inhibition by NADH was observed experimentally (Figure 4.6). Previous characterization 
of NoxV by Park et al. showed non-competitive inhibition by NAD+ [49]. NoxV showed 
a KM value at 50.2 µM towards NADH and KI at 289 µM towards NAD+. The apparent 
inhibition ratio must be less than unity in order to allow for theoretical complete 
conversion. Less than unity inhibition ratios were observed in the L-AmDH/NoxV 





 Figure 4.6 Inhibition patterns of L-AmDH towards NADH 
 
 
Table 4.5 Cofactor inhibition ratios for L-AmDH/NoxV reaction   Inhibition ratio Cross inhibition ratio L-AmDH: KM-NAD+/Ki-NADH 0.16   KM-NAD+/Ki-NAD+  0.14 NADH ox: KM-NADH/Ki-NAD+ 0.17   KM-NADH/Ki-NADH  0.19  
4.3.4 Optimization of oxidative deamination reaction conditions to achieve pure (S)-
amine  
After obtaining the kinetic parameters of the AmDHs and their respective reactions, 
reaction conditions were investigated to achieve optimal conversion of the (R)-amine. 
Various conditions were initially investigated in the 1-PEA (1) reaction and then further 
applied to the other oxidative deamination reactions (same reaction conditions unless 
otherwise noted in Experimental Section). First, various reaction buffers were considered 
(Table D.1). Ammonium buffer is not needed for the reaction to proceed in the oxidative 
deamination direction and NoxV deactivates in high ammonium concentrations. 0.1 M 
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glycine pH 8.0 was ultimately chosen as the buffer for all future oxidative deamination 
reactions.  
 The optimum reaction temperature was 35°C (Table D.2) due to the thermal 
instability of NoxV. Various enzyme ratios of L-AmDH to NoxV were investigated to 
allow for efficient cofactor regeneration. An optimum ratio of 6:1 of L-AmDH to NoxV 
was observed and used in further reactions (Table D.3). Different initial NAD+ 
concentrations were added into the reaction (Table D.4) and it was found that at least 10 
mM NAD+ must always be present in the reaction solution in order to achieve optimal 
conversion, indicating poor cofactor recycling. The KM value towards the cofactor 
NADH/NAD+ of all AmDHs and NoxV is around 45 µM (as previously described) so the 
low conversion can solely be attributed to inefficient cofactor regeneration leading to a 
build-up of NADH. Despite improvement to the thermostability to the NADH oxidase, no 
improvement was observed with the K147R variant in the reaction and further work must 
be done to optimize cofactor recycling.  
 Despite inefficient cofactor recycling, full conversion of 20 mM (R/S)-1-PEA (1) 
was achieved. The conditions were applied to 10 mM racemic amine mixtures (2 through 
5) and pure (S)-amine was obtained in all reactions (Table 4.6, Figure 4.7). Additional 
GC chromatograms and peak areas for both enantiomers are located Appendix E (Figure 






Table 4.6 Enantioselectivity of oxidative deamination reaction of racemic amine 
mixtures  Enantioselectivity (%) 1-PEA (1) 99.20 1-(2-napthyl)ethylamine (2) 99.32 2-aminohexane (3) 99.59 1,3-DMBA (4) 99.09 3,3-DMBA (5) 99.70 All enantioselectivity was determined by GC, except 1-(2-napthyl)ethylamine which was determined by HPLC.   
 Figure 4.7 GC chromatogram of oxidative deamination of racemic mixture (R/S)- 1-




Amine dehydrogenases (AmDHs) exhibit high enantioselectivity towards the (R)-amine 
and can be utilized to deracemize a racemic mixture in order to obtain enantiomerically 
pure (S)-amine (>99% e.e.). Protein engineering to improve oxidative deamination 
activity of all AmDHs and the thermostability of the NADH oxidase was achieved. 
Optimization of oxidative deamination reaction conditions was investigated and full 
conversion of (R)-amine was achieved. In summary, kinetic resolution of racemic amine 
mixtures was achieved for 1-phenylethylamine, 1-(2-napthyl)ethylamine, 2-aminohexane, 
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1,3-dimethylbutylamine and 3,3-dimethyl-2-butylamine to achieve their respective (S)-
amines. Future work will look into optimizing the cofactor recycling system and 




5APPLICATION OF AQUEOUS TWO PHASE EXTRACTION 
SYSTEM FOR EFFICIENT PURIFICATION OF 
DEHYDROGENASES 
 
5.1 Introduction & Motivation 
The recently developed amine dehydrogenases (AmDHs) produce enantiomerically pure 
amines used as pharmaceutical precursors and intermediates. Their potential as a 
biocatalytic green alternative for production toward chiral amines has led to the 
development of a scalable, efficient purification strategy for these enzymes. The current 
purification procedure requires affinity chromatography, specifically involving 
purification through His-tagged proteins (Figure 5.1) [114, 115]. This purification is 
expensive, requires multiple steps and is not cost-effective on a larger industrial scale 
(greater than one liter). This work seeks to develop an efficient, ‘one-step’ purification 
procedure of enzymes.  
 Figure 5.1 Current multi-step His-tag purification procedure [115] 
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This purification uses an aqueous two-phase extraction (ATPE) system with a polymer 
top phase and an aqueous salt buffer for the bottom phase. After homogenization of the 
bacterial cells, the cell lysate containing the desired protein was applied into the ATPE 
system. The ATPE system selectively partitions the desired enzyme (AmDH) into the top 
layer, while leaving the remaining cell debris and lysate to the bottom layer (Figure 5.2). 
The protein partitioning can be quickly determined by measuring the specific activity of 
the top and bottom layers. This ATPE is an economic, scalable and environmentally 
friendly alternative to traditional affinity protein purification. The polymer and salt 
components are cheap and non-toxic and no centrifugation or expensive Ni-NTA resin is 
required.  
 Notable recent separations with aqueous two-phase systems include amino acids 
[116], DNA [117], virus-like particles [118] and enzymes [119, 120]. Both phenylalanine 
dehydrogenase [121] and formate dehydrogenase [47, 122, 123] have been successfully 
purified with ATPE systems. This current thesis work involves 1) purification of F-
AmDH through the ATPE system, 2) scaling-up the purification and 3) further 
application to various dehydrogenases, including amine dehydrogenase enzymes and the 
cofactor regeneration enzymes. In addition, phase diagrams are established with 








5.2 Materials & Methods 
5.2.1 Chemicals 
Substrates were obtained from suppliers and used without further purification. PEG 1000 
was obtained from Spectrum Chemical (New Brunswick, NJ). PEG 1500 was obtained 
from Acros Organic (NJ, USA). PEG 4000, PEG 6000 and ammonium citrate tribasic 
were obtained from Alfa Aesar (War Hill, MA). PEG 8000 was obtained from 
GBiosciences (St. Louis, MO). Citric acid was obtained from Fisher Scientific (Fairlawn, 
NJ). Ammonium hydroxide was obtained from Ricca Chemical Company (Arlington, 
TX). Ammonium phosphate was obtained from Sigma Aldrich (St. Louis, MO) and 
ammonium bicarbonate was obtained from BDH Chemicals (West Chester, PA).  
 
5.2.2 Protein expression 
AmDH were expressed using the same procedure described in Section 2.2.2.  
 
5.2.3 Enzyme activity assay 
All UV-VIS analysis was performed as described in Section 2.2.3. 
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5.2.4 Preparation of cell debris and lysate 
The cell debris is created by the resuspension of cell pellets in 50 mM NaH2PO4 buffer 
containing 20 mM imidazole and 300 mM NaCl at pH 8.0. The mixture is sonicated at 14 
W for 1 minute ten times. To create the cell lysate, the sonicated cells were centrifuged at 
10,000 rpm for 30 minutes. 
 
 
5.2.5 Aqueous two-phase extraction procedure 
To create a small-scale ATPE system, the salt ammonium citrate is first added into the 
system. Next, potassium phosphate buffer pH 8.0 or Tris-Cl buffer pH 10.4 is added and 
the system is adjusted to the desired pH with ammonium hydroxide. Next, the polymer 
polyethylene glycol (PEG) is added and the mixture is vortexed to form a homogenous 
solution. All components are added based on the desired weight percent and the entire 
system was a total weight of 10 grams. The cell lysate is then added 20% (w/w) and the 
ATPE system is mixed for an hour to again form a homogenous solution.  The system is 
then centrifuged for 30 minutes at 4000 rpm at room temperature to form two distinct 
layers. For a large-scale ATPE system, citric acid is added and ammonium hydroxide is 
added to obtain the desired pH. The same procedure is followed with the desired volume 
and weight percent of each component and the cell lysate is added last at 20% (w/w).  
 The top and bottom layers are measured for catalytic activity UV-VIS 
spectrophotometry to quickly determine the partitioning of the enzyme. The protein 
concentration was determined by Bradford assay [75]. The enzymatic units in the top and 
bottom layers were calculated and compared to the total enzymatic units put into the 
system to determine the partitioning of the enzyme and if there was any loss of enzymatic 
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activity during the purification process (check of the mass balances). In addition, the top 
and bottom phases are run on a SDS-PAGE gel to observe the enzyme’s purity. The salt 
is removed from the sample solution through trichloroacetic acid (TCA) precipitation of 
the protein. One volume of 100% (w/v) TCA solution is added to four volumes of protein 
sample. The protein is precipitated from the mixture by centrifugation and then washed 
five times with acetone.  
 
5.2.6 Determination of phase diagrams 
To determine the binodal curve, stock solution of both the polymer and salt solution are 
prepared. The stock solutions are added drop-wise at known weights until the first sign of 
turbidity is observed, the cloud point. The solution is vortexed for one minute and then 
centrifuged for five minutes to form two distinct layers. Next, the diluent water is added 
to get below the cloud point to obtain a clear mixture and the procedure is repeated again. 
The amount of each component in the system to form one or two layers is recorded [124, 
125].   
 To define the tie-lines of a phase diagram, the composition of polymer and salt in 
the top and bottom phases must be determined. The top and bottom phases were diluted 
1:10 with water and then measured by a conductivity meter (Corning Conductivity Meter 
441) to determine the salt composition. The polymer concentration was determined by a 
refractometer (G.N. Wood, Newton, PA). The top and bottom phases were diluted 1:10 
with water. Both the sample and the standard (consisting of the known amount of salt in 
each phase previously determined by the conductivity meter) were measured. Samples 
were measured in triplicates and with light at four different wavelengths 
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(green/blue/red/orange). The standard curve for amount of PEG 6000 in presence of 
3.42% ammonium citrate is shown in Figure 5.3. The y-axis represents the difference in 
the light source reading between the sample and solvent. The composition of the polymer 
can also be determined by lyophilizing the top and bottom phases and obtaining the dry 
weight of polymer and salt. The previously determined salt composition was subtracted 
from the total dry weight of the phase to determine the polymer composition [124, 125].  
 
 Figure 5.3 Standard curve of the amount of PEG 6000 in 3.42% of ammonium citrate 
 
5.3 Results & Discussion 
5.3.1 Screening of various conditions for the F-AmDH 
Various conditions were tested to achieve optimal separation of the phenylalanine amine 
dehydrogenase (F-AmDH) in an aqueous two-phase extraction (ATPE) system. Previous 
work showed purification of B. sphaericus phenylalanine dehydrogenase with 9% (w/w) 
PEG 6000 and 16% (w/w) (NH4)2SO4 at pH 8.0 [121]. Various salts were considered 
(Table 5.1) and ammonium citrate was chosen as the best salt for the system. Ammonium 
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citrate is not expensive and non-toxic, which leads to easy disposal. Ammonium citrate 
has not been utilized in ATPE systems thus far, so its development in this work will be 
completely novel. Various amounts of ammonium citrate are added into the system (14 to 
16%) and optimal separation was achieved with 16% ammonium citrate (Table 5.2). All 
this work was performed with 9% (w/w) PEG 6000 at pH 8.0. The top and bottom layers 
for purification of F-AmDH in ATPE are shown in Figure 5.4.  
 
Table 5.1 Ratio of catalytic activity of top and bottom layers for F-AmDH with various 
salts (PEG 6000, pH 8.0) 
 Ratio 
(NH4)3PO4 (phosphate) 8.98 (NH4)HCO3 (bicarbonate) Did not separate NH4C6H17N3O7 (citrate) 10.06  
 
 
Table 5.2 Ratio of catalytic activity of top and bottom layers for F-AmDH at various 
concentrations of ammonium citrate (PEG 6000, pH 8.0) 
Ammonium citrate Top Layer (U/mg) Bottom Layer 
(U/mg) 
Ratio 
14% 6.12 1.43 4.29 
14.5% 6.39 1.04 6.17 
15% 6.09 0.48 12.59 
16% 6.46 0.053 123 
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 Figure 5.4 SDS purification of F-AmDH through ATPE, (A) top layer 1:10, (B) bottom 
layer 
 
5.3.2 Scale-up of F-AmDH ATPE purification 
The ATPE purification of F-AmDH was scaled up ten times (total weight 100 grams) 
using the optimal conditions described in the previous section. No centrifugation was 
performed because centrifugation is not feasible on a larger industrial scale. The system 
was allowed to settle in the 4°C fridge over a course of 3 days (Figure 5.5A through 
Figure 5.5C). Optimal separation was achieved after two days with a ratio of 7.68 of top 










 Figure 5.5 Larger-scale purification of F-AmDH through ATPE after (A) 30 minutes, (B) 
one day, (C) two days 
 
 
5.3.3 Application to various dehydrogenases 
The same conditions for the F-AmDH ATPE purification were applied to various 
dehydrogenases. There was no success in selectively partitioning the enzyme into the top 
layer with other dehydrogenases following the same conditions (Table 5.3). In addition, 
there was limited success with varying the molecular weight of the polymer. The ratios of 
the catalytic activity of the top to bottom layers are shown in Table 5.3. Values greater 
than unity represent more of the desired enzyme into the top layer (highlighted in green), 
while values less than unity represent more into the bottom layer (highlighted in red). 
Only F-AmDH and L-AmDH achieved sufficient protein purification into the top layer 
by varying the molecular weight.  
 
Table 5.3 ATPE purification of various dehydrogenases 
 PEG 400 PEG 1000 PEG 1500 PEG 4000 PEG 6000 PEG 8000 
F-AmDH  89.34 38.98 47.45 123 6.2 
cFL1-AmDH 0.44 0.081 0.115 0.275 0.067  
L-AmDH  16.19 19.34 1.6 0.17  
Formate DH 0.935 0.07 0.155 0.0205 0.085  
Glucose DH  0.63 0.0004 0.0044 0.031 0.0086 
Partition coefficient= [target protein]top/[target protein]bot 
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The impact of pH was investigated in the ATPE purification of cFL1-AmDH. As shown 
in Table 5.4, as the pH is increased, more of the cFL1-AmDH moved into the top layer. It 
is hypothesized that the pH of the ATPE can play a role in the folding of the protein 
(depending on its isoelectric point and the charge/pKa of its amino acids responsible for 
the protein structure). In addition, cFL1-AmDH has a high temperature optimum (>60°C) 
so the cell debris is incubated at 45°C for 30 minutes. Many of the other unwanted 
proteins in the solution begin to denature and become insoluble, allow for easier and 
cleaner protein separation and purification. The protein purification of cFL1-AmDH is 
shown on a SDS-PAGE gel (Figure 5.6). 
 
Table 5.4 Impact of pH on the purification of cFL1-AmDH (PEG 1500, cell lysate is 
treated to incubation at 45°C) 
pH Top Layer (U/mg) Bottom Layer (U/mg) Ratio 
8.0 0.49 0.18 2.75 
9.0 0.65 0.13 5 




 Figure 5.6 SDS purification of cFL1-AmDH through ATPE, (A) cell lysate incubated at 
45°C, (B) PEG 1000 top layer, (C) PEG 1000 bottom layer, (D) PEG 1500 top layer, (E) 
PEG 1500 bottom layer 
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Raising the pH for the ATPE systems also improved the protein partitioning of the 
cofactor regeneration enzymes formate and glucose dehydrogenase. However, the ATPE 
purification was still not acceptable as a protein purification method. Previous studies 
have shown the addition of salts, such as NaCl, can strongly affect the ATPE. The effect 
can be attributed to hydrophobic interactions [126, 127]. The addition of NaCl helped to 
improve the partitioning of the cofactor regeneration enzymes and achieve protein 
purification similar to His-tagged purification. The addition of NaCl did not help the 
partitioning of any of the AmDHs. The optimized conditions for each enzyme are listed 
in Table 5.5. Activity yield describes how much protein activity units are present in the 
system, top or bottom layer (ideally should be 100%). Purification yield indicates how 
clean the desired protein is in the top layer (activity of ATPE purified protein compared 
to activity of His-tagged purified protein). Further work includes scaling-up the ATPE, 
back extraction out of the polymer layer and ammonium sulfate precipitation of the 
protein solution [data not shown, work performed by Dr. Bettina Bommarius]. 
 
Table 5.5 Optimal ATPE purification conditions 
 Best ATPS condition Activity Yield Purification Yield 
F-AmDH: PEG 6000 pH 8.0 85.7% 99.4% 
L-AmDH: PEG 1500 pH 8.0 94.1% 100.1% 
cFL1-AmDH: PEG 4000 pH 9.5 90.28% 89.23% 
Formate DH: PEG 1500 pH 10.0, 10% NaCl 89.8% 89.2% 
Glucose DH: PEG 1000 pH 10.0, 10% NaCl 98.83% 91.38% 
  
5.3.4 Phase diagrams: Determination of binodal curve 
A binodal curve was established to determine the region of component concentrations 
that will form two phases in the ATPE system. All components above the curve will form 
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two immiscible aqueous phases; all components below the curve will only form one 
phase. Previously established phase diagrams are listed in Table 5.6. No phase diagrams 
have been determined using ammonium citrate as the salt. As can be seen from Figure 
5.7, different binodal curves are observed depending on the polymer used in the ATPE 
system. The larger the molecular weight of the polymer, the less amount of polymer and 
salt must be added into the system to form two layers.  
 
Table 5.6 Phase diagrams previously established in literature 
PEG Salt Ref 
2000, 4000, 6000, 8000 Potassium phosphate, sodium citrate [127] 
1500, 8000 Potassium citrate/formate, sodium citrate/formate [128] 
1000, 2000, 3400 Potassium phosphate, ammonium sulfate, K2CO3, Li2SO4, MnSO4, NaOH, ZnSO4 
[129] 
1000, 3350, 8000 Potassium phosphate, ammonium sulfate, sodium 
carbonate/sulfate, magnesium sulfate 
[130] 
600, 1000,1450, 3350, 8000 Sodium citrate [131] 
2000 Sodium citrate [132] 





 Figure 5.7 Binodal curve diagrams for PEG 1500 (A), PEG 6000 (B) and PEG 8000 (C) 






5.3.5 Phase diagrams: Determination of tie-lines 
After the determination of the binodal curve, all systems that form two immiscible 
aqueous phases will lie on a tie-line. All systems along a tie-line will have the same final 
concentration of polymer and salt components in both the top and bottom phases, 
respectively, but different total compositions and phase ratios [124, 125, 134]. The tie-
line length (TLL) is described by Equation 5.1 and the slope of the tie-line (STL) is 
described by Equation 5.2. ∆X is the difference in the salt composition between the top 
and bottom phases, ∆Y is the difference in the polymer composition between the top and 
bottom phases. All components on a tie-lie will have the same TLL and STL.  
 
TLL = ∆X + ∆Y /            [Equation 5.1] 
STL = ∆Y ∆X                         [Equation 5.2] 
 
The phase diagram consisting of PEG 6000 at pH 8.0 with its respective tie-lines are 
shown in Figure 5.8. The salt concentration was determined by a conductivity meter and 
the polymer concentration was determined by a refractometer. The slopes of the tie-lines 
are not truly parallel and future work will look at improving the mass balances 
(approximately 10% off). Tie-lines are useful in determining the optimal conditions to 
achieve protein separation by knowing the polymer and salt composition of the top and 
bottom phases. In addition, phase diagrams will likely change when the cell lysate is 




 Figure 5.8 Tie-lie diagrams for PEG 6000 with ammonium citrate as the salt (at pH 8.0) 
 
5.4 Conclusion 
An efficient aqueous two-phase extraction (ATPE) system has been developed for the F-
AmDH and applied to other dehydrogenases, including the amine dehydrogenase family. 
Successful small-scale purification of dehydrogenases was achieved and further work 
includes large-scale purification and back extraction out of the top polymer phase [work 
performed by Dr. Bettina Bommarius]. Initial phase diagrams have been created for our 
purification system. This purification procedure offers an efficient and environmentally 




6RECOMMENDATIONS AND CONCLUSIONS 
 
6.1  Recommendations 
6.1.1 Create variants to lower KM value of ammonia of the amine dehydrogenases 
The affinity towards ammonia for the amine dehydrogenases is still twenty times lower 
than for the amino acid dehydrogenases. Further work should focus on improving the KM 
value toward the ammonia substrate. The work described in Section 3.3.7 in Chapter 3 
suggests that cysteine or histidine may be the residue responsible for the binding of 
ammonia substrate. First, the same pH studies involving kcat and KM value towards 
ammonia should be repeated with the F-AmDH (as shown in Figure 3.16) in deuterated 
ammonia and fit to a double ionization model. If a cysteine residue is truly responsible 
for the binding of ammonia, pKa1 will shift 0.2 pH units. Cysteines located within the 
binding pocket of the F-AmDH include C52, C78, C141, C252 and C354. These 
cysteines should be mutated to alanine to determine if they are critical for catalysis and 
substrate binding. After determining which residue is important, surrounding residues 
should be mutated to maintain the correct protonation state within the active site (it is 
desired to deprotonate the cysteine residue). There is no histidine within the binding 
pocket of the F-AmDH. In addition, the residues R53, T123 and D131, should be closely 
investigated because previous mutations caused a dramatic decrease in the binding of 
ammonia and increase in the KM value (Appendix B, Figure 6.1).  
 In addition, further work should look at different substrates with more electron 
withdrawing groups. Different substituents on the phenyl ring (Hammett correlation, 
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Figure C.2) did not have an impact on the binding of the ammonia substrate but did have 
an impact on catalytic activity [data discussed in Section 3.3.4]. Substituents on the 
methyl group should now be investigated because the difference between the substrates 
of the amino acid dehydrogenase and an amine dehydrogenase is the carboxyl attached 
instead of the methyl group. 2-chloro acetophenone and 2,2,2-trifluoro acetophenone 
both contain a substituent on the methyl group but the amine dehydrogenase showed no 
activity toward either substrate.    
 
 Figure 6.1 Impact of T123 mutations on the binding of ammonia 
 
 
6.1.2 Expand the amine dehydrogenase family (V-AmDH and F-AmDH) 
During the evolutionary route of creating AmDHs, the K77S and N275L mutations 
(PheDH nomenclature) were identified as essential to produce chiral amines. It is further 
suspected that these mutations are broadly applicable across the Glu-Leu-Phe-Val 
dehydrogenase sub-family. Streptomyces cinnamonensis valine dehydrogenase was 
chosen as the scaffold because it has previously been expressed in the pET-28a/ BL21 
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system [136, 137]. Previous work (performed by M.J. Abrahamson) codon optimized the 
gene because of the high GC content (around 71% GC-pairs). Characterization of the 
codon optimized valine dehydrogenase (ValDH) led to poor expression and only 9 to 16 
U/mg of catalytic activity towards L-valine.  
 With the addition of mutations K76S and N272L, valine amine dehydrogenase 
(V-AmDH) was created exhibiting conversion of 2-methyl-3-butanone to (R)-1,2-
dimethylpropyl amine (Figure 6.2). Conversion was observed via HPLC analysis, mass 
spectrometry and NMR [data not shown]. It exhibits a KM value of around 20 mM for 2-
methyl-3-butanone and 13 µM for NADH. The substrate profile for the V-AmDH is 
listed in Table 6.1. V-AmDH unexpectedly has activity toward pFPA but not for MIBK. 
Further work should focus on improving the catalytic activity, substrate range and protein 
expression of the V-AmDH. Switching to another valine dehydrogenase gene may be 
necessary to improve the protein expression; possible genes could include Streptomyces 
aureofaciens [138] and Streptomyces albus [139]. 
 








Table 6.1 Valine AmDH substrate profile 
 Val-AmDH activity (U/mg) 
Methyl isobutyl ketone (MIBK): 0.06 






The Rhodococcus sp. phenylalanine DH could not be successfully mutated to create F-
AmDH because adding mutations within the active site caused the protein to express in 
the insoluble fraction [data not shown]. However, Ye et al. were able to develop the 
Rhodococcus sp. F-AmDH [35]. It is critical that we develop our own Rhodococcus sp. 
F-AmDH because 1) the Rhodococcus sp. PheDH has been extensively studied- both the 
crystal structure and mechanism have been published [92, 93] and 2) the KM value of 
ammonia was not reported for the Rhodococcus sp. F-AmDH. It is worth developing 
another F-AmDH to investigate any differences in the substrate profile and binding of 
ammonia. Future work should first look into improving the low expression of the wild-
type Rhodococcus sp. phenylalanine dehydrogenase. 
 
6.1.3 Improvement of kinetic resolution reaction conditions  
The kinetic resolution reaction described in Chapter 4 exhibited poor reaction conditions- 
a significant amount of enzyme and cofactor NAD+ had to be added to the reaction. 
When working with stoichiometric amounts of NAD+, the reaction would drastically slow 
down around 80 to 90% conversion, giving less than 95% e.e. To convert 5 mM of (R)-
amine, 5 to 10 equivalents of NAD+ had to be added to drive the reaction to completion 
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and achieve greater than 99% e.e. (procedure described in Section 4.2.6). Further work 
should investigate and seek to improve the reaction conditions.  
 First, the conditions of the kinetic resolution reaction should be changed to allow 
for more oxygen transfer for the Lactobacillus plantarum NADH oxidase. The reaction 
vessel should change from a 1.7 mL Eppendorf tube to a 4 mL glass tube. A stir bar 
should be implemented to facilitate oxygen transfer in the beginning. Furthermore, a 
different NADH oxidase should also be investigated because it is suspected there is 
inefficient cofactor recycling in the reaction, causing a large amount of NAD+ to be 
added into the reaction to achieve full conversion. Lactobacillus plantarum NADH 
oxidase currently exhibits high instability and begins to deactivate after 2 hours at room 
temperature [previously determined by Dr. Jonathan T. Park]. Without any NADH 
oxidase present, 78.17% conversion can already be achieved by just constantly adding 
NAD+ into the system. Another NADH oxidase from Lactobacillus sanfrancensis should 
be expressed and purified to determine if it can be a more effective cofactor regeneration 
enzyme for kinetic resolution reactions. Temperature stability and activity studies should 
be performed. 
 The incorporation of a biphasic organic solvent system should be investigated. 
Different organic solvents include heptane, MTBE, toluene and chloroform and the 
reaction conditions described in Chapter 2 should be utilized. The product can be 
constantly removed by partitioning into the organic solvent from the aqueous medium 
[140]. The substrate can also be constantly added throughout the reaction to avoid any 




6.1.4 Switch the enantioselectivity of the amine dehydrogenases 
Asymmetric synthesis offers an advantage over kinetic resolution (as described in 
Chapter 4) in the production of pure enantiomers because of its 100% theoretical yield 
compared to 50% for kinetic resolution [141, 142]. However, the “mirror-image” enzyme 
most often is not available and thus only one but not both enantiomers are accessible 
through asymmetric synthesis. To develop a broad spectrum of possible API candidates 
for testing of drug efficacy, both enantiomers of the product amine are desired. To change 
the selectivity of the enzyme, residues located in the active site close to the residues 
participating in the chemical conversion of the substrate should be investigated. Studies 
of naturally occurring enantiocomplementary enzymes show that even though the pair 
catalyzes the same reaction, they can have different overall protein structures along with 
different functional groups located in the active site [142]. Inversion of enantioselectivity 
has been achieved by changing the location of key catalytic residues in a reaction 
mechanism. Successful inversion was accomplished in arylmalonate decarboxylase by 
exchanging the proton-donating cysteine to the opposite side of the active site [143-145]. 
Substitutions with larger residues into the active site cause steric effects that can affect 
the binding of the substrate and lead to a switch of enantioselectivity [146]. 
 A high-throughput library was created with the attempt to switch the 
enantioselectivity of the AmDH from (R) to (S)-selectivity. The libraries were screened 
with Bacillus badius PheDH genes containing two different mutations located in the 
active site. The previous mutations introduced on the B. badius PheDH changed the 
substrate selectivity (K77 and N275), while these two new mutations are introduced with 
hopes to change the enantioselectivity (M74 and V308). Preservation of (S)-selectivity of 
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the PheDH will lead to formation of phenylpyruvate from (S)-phenylalanine. Wild-type 
activity toward phenylalanine was chosen as an assay for determining if inversion of 
enantioselectivity had been achieved because it is easier to screen in the deamination 
direction using an amine with already the desired enantioselectivity as the substrate. The 
substrate for F-AmDH, 1-(4-fluorophenyl)-propyl-2-amine, is only available as a 
racemate and is expensive. Successful variants will oxidize (R)-phenylalanine to 
phenylpyruvate. If these enantioselectivity mutations are successful, the addition of the 
previous mutations (K77S and N275L) can change substrate specificity toward pFPA.  
Restricted libraries on both residues were performed synergistically as M74VWS 
and V308DDS on the wild-type PheDH. 1152 colonies were expressed at 25 and 30°C 
and screened for activity towards (R)-phenylalanine. The wild-type PheDH has an 
activity of 0.14 U/mg towards (R)-phenylalanine so this must be taken into account when 
screening for hits. 20 clones showing the highest activities were expressed and purified 
but there was no improved activity toward (R)-phenylalanine compared to the wild-type 
phenylalanine dehydrogenase. Further work should look at further mutations within the 
active site. Mutations to the M74 residue have resulted in inactive protein because it is 
probably essential for catalysis so another residue should be investigated instead. The 








6.1.5 Investigate and expand the substrate profile of the amine dehydrogenases 
As shown in Table 4.3 in Chapter 4, L-AmDH unexpectedly shows activity toward (R)-1-
phenylethylamine (1-PEA) but little activity toward the ketone acetophenone (0.97 U/mg 
for deamination compared to 0.059 U/mg for amination, respectively). The same 
phenomenon was observed with the substrate (R)-3,3-DMBA and pinacolone with the L-
AmDH (1.43 U/mg for deamination compared to 0.054 U/mg for amination, 
respectively). There should be further investigation to determine why the L-AmDH 
displays drastic activity differences between reductive amination and oxidative 
deamination. Further mutations and their impact on the substrate profile on the L-AmDH 
are listed in Table 6.2. Neither the F-AmDH nor the cFL1-AmDH displays this unique 
substrate profile.  
 















MIBK 0.91 0 0.77 0.046 0.092 0.48 
1,3-DMBA 0.33 0.035 1.08 0.041 0.26 0.59 
Acetophenone 0.049 0 0.4 0 0.052 0.24 
PEA 0.7 0.017 0.93 0.06 0.2 0.79 
 
There are many pharmaceutically relevant substrates that were not substrates of the amine 
dehydrogenases, such as 5-diethylamine-2-pentanone, 2-acetylpyridine, mexiletine and 1-
(1-napthyl)ethylamine. Desired substrates should be modeled in AutoDock Vina® to 
determine the optimal binding conformation and what residues interact with the substrate. 
Rational design and directed evolution can be implemented to expand the current 
substrate profile of the amine dehydrogenases. The Y76 mutations opened up space in the 
binding pocket and improved catalytic activity of the F-AmDH towards pFPA up to 16 
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U/mg. Further work should test bulkier substrates with the Y76A variant and perform 
additional mutations within the active site (Figure 6.3).  
 
 Figure 6.3 Impact of Y76 mutations on the catalytic activity of F-AmDH 
 
 
6.1.6 Develop model to predict aqueous two-phase extraction system 
So far, the aqueous two-phase extraction (ATPE) systems have only been applied to 
amine dehydrogenases and the cofactor regeneration enzymes, glucose and formate 
dehydrogenases. The main disadvantage of the ATPE is in the inability to predict 
partitioning behavior and testing numerous conditions can be tedious and time-
consuming. Future work should focus on the purification of other enzymes beyond 
dehydrogenases and to develop a model to predict the partitioning behavior in an ATPE 
system.  
 First, the phase ratios at various polymer and salt concentrations (including NaCl) 
in an ATPE system should be thoroughly recorded and analyzed. The volume of each 
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phase is influenced by the amount of salt in the system (Figure 6.4) and molecular weight 
of the polymer (Figure 6.5) and can have an important impact on how the protein 
partitions between the two layers. The addition of NaCl affects the phase ratio as well as 
the formation of two immiscible aqueous layers (Figure 6.5). The pH did not have an 
impact on the phase ratios.  
 Figure 6.4 Impact of % (w/w) ammonium citrate on the volume ratio (PEG 1500, pH 5.5) 
 
 Figure 6.5 Impact of MW of PEG and addition of NaCl on the volume ratio (16 % (w/w) 




A model to predict which conditions are optimal for separation of each enzyme should 
take into account the molecular weight and amount of PEG, pH and type and amount of 
salt. If the molecular weight of the polymer is lower, the interfacial tension is decreased 
between the two phases [147]. In addition, the concentration of PEG impacts the 
hydrophobic interactions between the enzyme and polymer [148]. pH can impact the 
ATPE system through electrostatic interactions, depending on the isoelectric point and 
charge of the protein [149]. Lastly, the salts in the system affect the hydrophobicity and 
the ‘salting-out’ effect, which forces enzymes to move out of salt-rich phase to a PEG-
rich phase [150]. Some potentially important characteristic of the dehydrogenases from 
Chapter 5 that can be used to build a universal model and procedure for ATPE systems 
are listed in Table 6.3. 
 
 
Table 6.3 Characteristics of the dehydrogenases used in ATPE system 







at pH 7.0 
L-AmDH 367 40.46 5.56 -0.29 -8.5 
cFL1-AmDH 376 41.04 5.75 -0.23 -8.5 
F-AmDH 380 41.35 4.94 -0.2 -14.7 
GluDH 330 34.76 4.8 0.01 -8.9 
FDH 364 40.37 6.26 -0.28 -5.9 
 
6.2 Conclusions 
This work describes the development of the amine dehydrogenase for the enzymatic 
production of chiral amines. The substrate profile of the AmDHs was expanded to 
previously unattainable hydrophobic substrates with the incorporation of a biphasic 
organic solvent system. The initial study on the mechanism and binding of the ammonia 
substrate was extensively investigated on the novel AmDH through protein and reaction 
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engineering. Successful kinetic resolution reactions allowed for us to obtain the 
enantiomerically pure (S)-enantiomer (>99% e.e.). Lastly, the development of an aqueous 
two-phase extraction system was established and applied to dehydrogenases. The 
established purification protocol was very comparable to protein purification through 
affinity chromatography. Throughout the thesis work, various substrates were tested and 
protein engineering was performed with hopes to improve the specificity, activity and 
stability.  
 Future work should focus on preparing the amine dehydrogenase for industrial 
applications. The binding towards the ammonia substrate has to improve in order for the 
enzyme to be economically comparable to transaminases. Catalytically important amino 
acids within the active site of the AmDH should be investigated and mutated to maintain 
the correct protonation state. Any substrate or product inhibition should be studied so 
reactions of the AmDH can be continuously run at the optimal conditions. The substrate 
profile of the AmDH should constantly be expanded to cover more pharmaceutically 
relevant substrates and (S)-amines. Lastly, the aqueous two-phase extraction system 
should be applied to various enzymes, such as the alcohol dehydrogenases. A model 
should be developed to predict the protein partitioning in ATPE systems to avoid testing 









CHROMATOGRAMS FOR DEVELOPMENT OF BIPHASIC 
SYSTEM (CHAPTER 2) 
 
 Figure A.1 Investigation of partition coefficient of pFPA: aqueous layers partitioning 
with various organic solvents (a), partition comparison between heptane and aqueous 
layer (b). 
 Figure A.2 The effect of the phase ratio on the partitioning of hydrophobic substrates in 
the aqueous layer: pFPA (a), acetophenone (b), 3-methyl-1-phenyl-2-butanone (c).Very 
little 1-adamantyl methyl ketone is present in the aqueous phase so no respective 




 Figure A.3 Effect of stirring in the biphasic conversion of pFPA in the aqueous layer 
 
 
 Figure A.4 Initial monophasic conversion of pFPA (a) and acetophenone (b). 
 
 
 Figure A.5 Initial biphasic conversion of pFPA (a) and 3-methyl-1-phenyl-2-butanone 





PHENYLALANINE AMINE DEHYDROGENASE (F-AMDH) 
VARIANTS (CHAPTER 3) 
 
Table B.1 F-AmDH variants (base case= K77S/N275L) and their respective activity and 
KM-NH4. All activity was measured in 5 M NH4OH/CHOO- buffer at 25°C. 
Variant Specific Activity KM-NH4 
R53D None N/A 
R69D No change No change 
K192D No change No change 
A236D No change No change  
G200H/L202H No change No change 
R286D 1.5X less No change 
L49S 7X less No change 
L49A 3.5X less No change 
V143F None N/A 
V143S 1.5X less No change 
Y76L 2X more No change 
Y76F No change No change 
Y76K No change No change 
Y76S 1.5X more No change 
Y76A 2.5X more No change 
D124K None N/A 
D124H None N/A 
D124A None N/A 
T123P No change Worse (>1.5 M) 
T123C No change Worse (>1.5 M) 
T123G No change Worse (>1.5 M) 
T123N No change Worse (>1.5 M) 
T123K 4X less Worse (>1.5 M) 
N275K 4X less Worse (>1.5 M) 
K77K 50X less No change 
N276L 2.5X less No change 
N276Q 1.5X less No change 
N276H No change No change 
K89S No change No change 
K89S/Y76A No change Worse (>1.5 M) 
K89S (w/o K77S) 100X less N/A 
K89S (w/o N275L) 100X less N/A 
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Table B.1 (continued)   
K89S (w/o K77S/N275L) None N/A 
G50K None N/A 
G122K None N/A 
D82E No change No change 
D82K 4X less No change 
D131E No change Worse (>1.5 M) 
D131K 1.5X less Worse (>1.5 M) 
S155G 5X less Worse (>1.5 M) 
S155A 2X less No change 
S155K None N/A 
T123K/D131K 6X less Worse (>1.5 M) 
D124K/D131K None N/A 
K89M 10X less No change 
K89M/D124E None N/A 
G51K None N/A 
R53K No change Worse (>1.5 M) 
D88K None N/A 
N276K 2X less Worse (>1.5 M) 





AFFINITY TOWARDS AMMONIA AT VARIOUS BUFFER 
CONDITIONS (CHAPTER 3) 
 
 Figure C.1 Affinity towards ammonia with different ammonia buffers with F-AmDH. 
Activity measured at 25°C.  
 
 
 Figure C.2 Affinity towards ammonia with different substituents on the phenyl ring with 




Table C.1 Affinity towards pFPA at different pHs 
5 M NH4/CHOO- buffer Specific Activity (U/mg) KM-pFPA (mM) pH 11.5 1.65 2.87 
pH 11.0 4.08 2.09 
pH 10.0 5.34 3.03 
pH 9.6 6.47 4.61 
pH 9.0 5.39 2.19 
pH 8.0 2.74 1.99 
pH 7.0 1.21 1.3 





Table C.2 Affinity towards NADH at different pHs 
5 M NH4/CHOO- buffer Specific Activity (U/mg) KM-NADH (mM) pH 11.5 1.59 0.039 
pH 11.0 2.23 0.035 
pH 10.0 5.84 0.035 
pH 9.6 6.47 0.04 
pH 9.0 4.98 0.033 
pH 8.0 2.69 0.051 
pH 7.0 1.13 0.033 






Table C.3 Affinity towards ammonia at different pHs 
5 M NH4/CHOO- buffer Specific Activity (U/mg) KM-pFPA (mM) pH 11.5 1.09 675 
pH 11.0 3.5 796 
pH 10.0 5.68 698 
pH 9.6 6.47 637 
pH 9.0 5.33 799 
pH 8.0 2.65 779 
pH 7.0 1.31 1372 









OPTIMIZED REACTION CONDITIONS FOR OXIDATIVE 
DEAMINATION (CHAPTER 4) 
Table D.1 Activity of L-AmDH and NADH oxidase in various reaction buffers 







Ratio of Units 





30 10 25 3 to 1 24 64.01 
30 10 35 3 to 1 24 75.42 
30 10 45 3 to 1 24 67.77 
 
 
Table D.3 Investigation of various enzyme ratios of L-AmDH to NoxV   (R/S)-1-PEA (mM) NAD
+ (mM) Temperature (°C) Ratio of Units  (L-AmDH to Nox) 
Time (hours) Conversion (%) 
30 10 25 1 to 1 24 38.71 30 10 25 2 to 1 24 47.19 30 10 25 3 to 1 24 64.01 30 10 25 4 to 1 24 66.66 30 10 25 5 to 1 24 71.14 30 10 25 6 to 1 24 78.69 30 10 25 7 to 1 24 67.32 30 10 25 8 to 1 24 62.33 
 
 Table D.4 Investigation of various initial concentrations of NAD+ 
(R/S)-1-
PEA (mM) 
NAD+ (mM) Temperature 
(°C) 
Ratio of Units 





30 22.5 25 3 to 1 24 66.35 
30 10 25 3 to 1 24 66.12 
30 5 25 3 to 1 24 35.29 




CHROMATOGRAMS TO OBTAIN ENANTIOMERICALLY 
PURE (S)-AMINES (CHAPTER 4) 
  Figure E.1 GC chromatogram of oxidative deamination of racemic mixture (R/S)- 1-
phenylethylamine (1-PEA) to leave pure (S)-1-PEA. Standard of (R/S)-1-PEA (black), 
reaction sample (pink/blue) 
 
 Figure E.2 GC chromatogram of oxidative deamination of racemic mixture (R/S)-1,3-
dimethylbutylamine (DMBA) to leave pure (S)-1,3-DMBA. Standard of (R/S)-1,3-





  Figure E.3 GC chromatogram of oxidative deamination of racemic mixture (R/S)-3,3-
dimethyl-2-butyl amine to leave pure (S)-3,3-DMBA. Standard of (R/S)-3,3-DMBA 
(black), reaction sample (pink/blue). 
 
 Figure E.4 GC chromatogram of oxidative deamination of racemic mixture (R/S)-2-
aminohexane to leave pure (S)-2-aminohexane. Standard of (R/S)-2-aminohexane (black), 









 Figure E.5 HPLC chromatogram of oxidative deamination of 10 mM racemic mixture 
(R/S)-1-(2-napthyl)ethylamine to leave pure (S)-1-(2-napthyl)ethylamine. Time points: 12 
hours (black), 24 hours (pink), 36 hours (blue) and 48 hours (green). Reaction samples 
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